CN115521484A - Injectable colloidal gel material composed of polyphenol and protein composite particles and preparation method and application thereof - Google Patents
Injectable colloidal gel material composed of polyphenol and protein composite particles and preparation method and application thereof Download PDFInfo
- Publication number
- CN115521484A CN115521484A CN202211112129.2A CN202211112129A CN115521484A CN 115521484 A CN115521484 A CN 115521484A CN 202211112129 A CN202211112129 A CN 202211112129A CN 115521484 A CN115521484 A CN 115521484A
- Authority
- CN
- China
- Prior art keywords
- protein
- nanoparticles
- polyphenol
- particles
- composite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 171
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 171
- 235000013824 polyphenols Nutrition 0.000 title claims abstract description 153
- 150000008442 polyphenolic compounds Chemical class 0.000 title claims abstract description 151
- 239000011246 composite particle Substances 0.000 title claims abstract description 99
- 239000000463 material Substances 0.000 title claims abstract description 81
- 238000002360 preparation method Methods 0.000 title claims abstract description 31
- 239000002105 nanoparticle Substances 0.000 claims abstract description 272
- 239000000499 gel Substances 0.000 claims abstract description 136
- 239000000017 hydrogel Substances 0.000 claims abstract description 66
- 239000002131 composite material Substances 0.000 claims abstract description 53
- 230000003993 interaction Effects 0.000 claims abstract description 52
- 239000003431 cross linking reagent Substances 0.000 claims abstract description 48
- 238000004132 cross linking Methods 0.000 claims abstract description 42
- 239000003814 drug Substances 0.000 claims abstract description 30
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 28
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 27
- 239000001257 hydrogen Substances 0.000 claims abstract description 27
- 230000001590 oxidative effect Effects 0.000 claims abstract description 24
- 239000007800 oxidant agent Substances 0.000 claims abstract description 16
- 230000009471 action Effects 0.000 claims abstract description 14
- 230000002439 hemostatic effect Effects 0.000 claims abstract description 6
- 229920000642 polymer Polymers 0.000 claims abstract description 6
- 239000002245 particle Substances 0.000 claims description 171
- 239000000243 solution Substances 0.000 claims description 101
- 108010010803 Gelatin Proteins 0.000 claims description 80
- 239000000843 powder Substances 0.000 claims description 73
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 claims description 65
- 239000001263 FEMA 3042 Substances 0.000 claims description 65
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 claims description 65
- 235000015523 tannic acid Nutrition 0.000 claims description 65
- 229920002258 tannic acid Polymers 0.000 claims description 65
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 claims description 65
- 229940033123 tannic acid Drugs 0.000 claims description 65
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 59
- 239000007864 aqueous solution Substances 0.000 claims description 53
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 52
- 229910021645 metal ion Inorganic materials 0.000 claims description 51
- 239000011258 core-shell material Substances 0.000 claims description 35
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 32
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 30
- 108010022355 Fibroins Proteins 0.000 claims description 29
- -1 terbium ions Chemical class 0.000 claims description 29
- 239000002135 nanosheet Substances 0.000 claims description 26
- 239000000377 silicon dioxide Substances 0.000 claims description 26
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 claims description 26
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 22
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 21
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 20
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 20
- XXQBEVHPUKOQEO-UHFFFAOYSA-N potassium superoxide Chemical compound [K+].[K+].[O-][O-] XXQBEVHPUKOQEO-UHFFFAOYSA-N 0.000 claims description 20
- 239000000126 substance Substances 0.000 claims description 19
- 239000005312 bioglass Substances 0.000 claims description 18
- 239000006185 dispersion Substances 0.000 claims description 18
- 229910021389 graphene Inorganic materials 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 18
- 238000004108 freeze drying Methods 0.000 claims description 17
- 239000011701 zinc Substances 0.000 claims description 17
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 16
- IPGANOYOHAODGA-UHFFFAOYSA-N dilithium;dimagnesium;dioxido(oxo)silane Chemical compound [Li+].[Li+].[Mg+2].[Mg+2].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O IPGANOYOHAODGA-UHFFFAOYSA-N 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 16
- 239000012802 nanoclay Substances 0.000 claims description 16
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 16
- 239000004626 polylactic acid Substances 0.000 claims description 16
- 239000010949 copper Substances 0.000 claims description 15
- 239000002122 magnetic nanoparticle Substances 0.000 claims description 15
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 14
- 239000004698 Polyethylene Substances 0.000 claims description 14
- 239000004793 Polystyrene Substances 0.000 claims description 14
- JRPBQTZRNDNNOP-UHFFFAOYSA-N barium titanate Chemical compound [Ba+2].[Ba+2].[O-][Ti]([O-])([O-])[O-] JRPBQTZRNDNNOP-UHFFFAOYSA-N 0.000 claims description 14
- 229910002113 barium titanate Inorganic materials 0.000 claims description 14
- 239000002041 carbon nanotube Substances 0.000 claims description 14
- 229910021393 carbon nanotube Inorganic materials 0.000 claims description 14
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims description 14
- 229910052751 metal Inorganic materials 0.000 claims description 14
- 229920000573 polyethylene Polymers 0.000 claims description 14
- 229920002223 polystyrene Polymers 0.000 claims description 14
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 13
- 239000002184 metal Substances 0.000 claims description 13
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 claims description 12
- 239000012460 protein solution Substances 0.000 claims description 12
- JHWIEAWILPSRMU-UHFFFAOYSA-N 2-methyl-3-pyrimidin-4-ylpropanoic acid Chemical compound OC(=O)C(C)CC1=CC=NC=N1 JHWIEAWILPSRMU-UHFFFAOYSA-N 0.000 claims description 11
- 235000012239 silicon dioxide Nutrition 0.000 claims description 11
- PFUVRDFDKPNGAV-UHFFFAOYSA-N sodium peroxide Chemical compound [Na+].[Na+].[O-][O-] PFUVRDFDKPNGAV-UHFFFAOYSA-N 0.000 claims description 11
- 239000004373 Pullulan Substances 0.000 claims description 10
- 229920001218 Pullulan Polymers 0.000 claims description 10
- 239000000783 alginic acid Substances 0.000 claims description 10
- 235000010443 alginic acid Nutrition 0.000 claims description 10
- 229920000615 alginic acid Polymers 0.000 claims description 10
- 229960001126 alginic acid Drugs 0.000 claims description 10
- 150000004781 alginic acids Chemical class 0.000 claims description 10
- 150000001413 amino acids Chemical class 0.000 claims description 10
- 238000004140 cleaning Methods 0.000 claims description 10
- 239000012792 core layer Substances 0.000 claims description 10
- 239000002366 mineral element Substances 0.000 claims description 10
- 239000012286 potassium permanganate Substances 0.000 claims description 10
- 235000019423 pullulan Nutrition 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- 229940088594 vitamin Drugs 0.000 claims description 10
- 235000013343 vitamin Nutrition 0.000 claims description 10
- 239000011782 vitamin Substances 0.000 claims description 10
- 229930003231 vitamin Natural products 0.000 claims description 10
- 230000003647 oxidation Effects 0.000 claims description 9
- 238000007254 oxidation reaction Methods 0.000 claims description 9
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 8
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 8
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 claims description 8
- 229910052684 Cerium Inorganic materials 0.000 claims description 8
- 229920001661 Chitosan Polymers 0.000 claims description 8
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 8
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 8
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 8
- MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical compound OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 claims description 8
- 229910052693 Europium Inorganic materials 0.000 claims description 8
- 229910052688 Gadolinium Inorganic materials 0.000 claims description 8
- AZKVWQKMDGGDSV-BCMRRPTOSA-N Genipin Chemical compound COC(=O)C1=CO[C@@H](O)[C@@H]2C(CO)=CC[C@H]12 AZKVWQKMDGGDSV-BCMRRPTOSA-N 0.000 claims description 8
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 8
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims description 8
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 8
- 229920002472 Starch Polymers 0.000 claims description 8
- 101710172711 Structural protein Proteins 0.000 claims description 8
- PCSMJKASWLYICJ-UHFFFAOYSA-N Succinic aldehyde Chemical compound O=CCCC=O PCSMJKASWLYICJ-UHFFFAOYSA-N 0.000 claims description 8
- 229910052771 Terbium Inorganic materials 0.000 claims description 8
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 8
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 claims description 8
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 claims description 8
- 229910052782 aluminium Inorganic materials 0.000 claims description 8
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 8
- 229910052793 cadmium Inorganic materials 0.000 claims description 8
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 claims description 8
- 150000001718 carbodiimides Chemical class 0.000 claims description 8
- ZMIGMASIKSOYAM-UHFFFAOYSA-N cerium Chemical compound [Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce] ZMIGMASIKSOYAM-UHFFFAOYSA-N 0.000 claims description 8
- 229940045110 chitosan Drugs 0.000 claims description 8
- 229940059329 chondroitin sulfate Drugs 0.000 claims description 8
- 229910052804 chromium Inorganic materials 0.000 claims description 8
- 239000011651 chromium Substances 0.000 claims description 8
- 229910017052 cobalt Inorganic materials 0.000 claims description 8
- 239000010941 cobalt Substances 0.000 claims description 8
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims description 8
- 229910052802 copper Inorganic materials 0.000 claims description 8
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 claims description 8
- 125000005442 diisocyanate group Chemical group 0.000 claims description 8
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 claims description 8
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 claims description 8
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 claims description 8
- AZKVWQKMDGGDSV-UHFFFAOYSA-N genipin Natural products COC(=O)C1=COC(O)C2C(CO)=CCC12 AZKVWQKMDGGDSV-UHFFFAOYSA-N 0.000 claims description 8
- 229920002674 hyaluronan Polymers 0.000 claims description 8
- 229960003160 hyaluronic acid Drugs 0.000 claims description 8
- 239000000976 ink Substances 0.000 claims description 8
- 229910052742 iron Inorganic materials 0.000 claims description 8
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 8
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims description 8
- 229910052750 molybdenum Inorganic materials 0.000 claims description 8
- 239000011733 molybdenum Substances 0.000 claims description 8
- 229910052759 nickel Inorganic materials 0.000 claims description 8
- 238000007639 printing Methods 0.000 claims description 8
- 229910052703 rhodium Inorganic materials 0.000 claims description 8
- 239000010948 rhodium Substances 0.000 claims description 8
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 claims description 8
- 229910052707 ruthenium Inorganic materials 0.000 claims description 8
- 239000008107 starch Substances 0.000 claims description 8
- 235000019698 starch Nutrition 0.000 claims description 8
- 210000001519 tissue Anatomy 0.000 claims description 8
- 229910052720 vanadium Inorganic materials 0.000 claims description 8
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 claims description 8
- 229920001285 xanthan gum Polymers 0.000 claims description 8
- 239000000230 xanthan gum Substances 0.000 claims description 8
- 235000010493 xanthan gum Nutrition 0.000 claims description 8
- 229940082509 xanthan gum Drugs 0.000 claims description 8
- 229910052725 zinc Inorganic materials 0.000 claims description 8
- 229910052726 zirconium Inorganic materials 0.000 claims description 8
- 150000003934 aromatic aldehydes Chemical class 0.000 claims description 7
- 108010076876 Keratins Proteins 0.000 claims description 6
- 102000011782 Keratins Human genes 0.000 claims description 6
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 claims description 6
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 claims description 6
- 239000000853 adhesive Substances 0.000 claims description 6
- 230000001070 adhesive effect Effects 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 102000034287 fluorescent proteins Human genes 0.000 claims description 6
- 108091006047 fluorescent proteins Proteins 0.000 claims description 6
- 229940074391 gallic acid Drugs 0.000 claims description 6
- 235000004515 gallic acid Nutrition 0.000 claims description 6
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 claims description 6
- 239000010410 layer Substances 0.000 claims description 6
- 239000002905 metal composite material Substances 0.000 claims description 6
- 239000004005 microsphere Substances 0.000 claims description 6
- 235000005875 quercetin Nutrition 0.000 claims description 6
- 229960001285 quercetin Drugs 0.000 claims description 6
- 238000007789 sealing Methods 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 108060003951 Immunoglobulin Proteins 0.000 claims description 5
- 230000009881 electrostatic interaction Effects 0.000 claims description 5
- 102000018358 immunoglobulin Human genes 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 108010014258 Elastin Proteins 0.000 claims description 4
- 102000016942 Elastin Human genes 0.000 claims description 4
- 102000009123 Fibrin Human genes 0.000 claims description 4
- 108010073385 Fibrin Proteins 0.000 claims description 4
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims description 4
- 102000001554 Hemoglobins Human genes 0.000 claims description 4
- 108010054147 Hemoglobins Proteins 0.000 claims description 4
- 108010013296 Sericins Proteins 0.000 claims description 4
- 206010052428 Wound Diseases 0.000 claims description 4
- 208000027418 Wounds and injury Diseases 0.000 claims description 4
- 230000000844 anti-bacterial effect Effects 0.000 claims description 4
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 claims description 4
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims description 4
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 claims description 4
- 229920002549 elastin Polymers 0.000 claims description 4
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 claims description 4
- 229950003499 fibrin Drugs 0.000 claims description 4
- 238000011049 filling Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 230000000087 stabilizing effect Effects 0.000 claims description 4
- 238000007920 subcutaneous administration Methods 0.000 claims description 4
- 239000003106 tissue adhesive Substances 0.000 claims description 4
- 108010071390 Serum Albumin Proteins 0.000 claims description 3
- 102000007562 Serum Albumin Human genes 0.000 claims description 3
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 3
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 230000003078 antioxidant effect Effects 0.000 claims description 3
- 235000006708 antioxidants Nutrition 0.000 claims description 3
- 239000006285 cell suspension Substances 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 230000007547 defect Effects 0.000 claims description 3
- 238000001727 in vivo Methods 0.000 claims description 3
- 108020004707 nucleic acids Proteins 0.000 claims description 3
- 102000039446 nucleic acids Human genes 0.000 claims description 3
- 150000007523 nucleic acids Chemical class 0.000 claims description 3
- 239000002861 polymer material Substances 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 238000010146 3D printing Methods 0.000 claims description 2
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 claims description 2
- 230000003444 anaesthetic effect Effects 0.000 claims description 2
- 230000001093 anti-cancer Effects 0.000 claims description 2
- 230000000840 anti-viral effect Effects 0.000 claims description 2
- 230000003115 biocidal effect Effects 0.000 claims description 2
- 210000004204 blood vessel Anatomy 0.000 claims description 2
- 210000000988 bone and bone Anatomy 0.000 claims description 2
- 210000000845 cartilage Anatomy 0.000 claims description 2
- 235000012754 curcumin Nutrition 0.000 claims description 2
- 229940109262 curcumin Drugs 0.000 claims description 2
- 239000004148 curcumin Substances 0.000 claims description 2
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 claims description 2
- 229960003638 dopamine Drugs 0.000 claims description 2
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 claims description 2
- 239000000945 filler Substances 0.000 claims description 2
- 239000003102 growth factor Substances 0.000 claims description 2
- 239000005556 hormone Substances 0.000 claims description 2
- 229940088597 hormone Drugs 0.000 claims description 2
- 229920001477 hydrophilic polymer Polymers 0.000 claims description 2
- 230000007365 immunoregulation Effects 0.000 claims description 2
- 210000003205 muscle Anatomy 0.000 claims description 2
- 210000003491 skin Anatomy 0.000 claims description 2
- 230000037314 wound repair Effects 0.000 claims description 2
- 239000002537 cosmetic Substances 0.000 claims 1
- 208000037816 tissue injury Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 abstract description 9
- 208000031737 Tissue Adhesions Diseases 0.000 abstract description 7
- 238000013268 sustained release Methods 0.000 abstract description 2
- 239000012730 sustained-release form Substances 0.000 abstract description 2
- 239000000969 carrier Substances 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 description 79
- 229920000159 gelatin Polymers 0.000 description 79
- 235000019322 gelatine Nutrition 0.000 description 78
- 235000011852 gelatine desserts Nutrition 0.000 description 78
- 239000008367 deionised water Substances 0.000 description 42
- 229910021641 deionized water Inorganic materials 0.000 description 42
- 210000004027 cell Anatomy 0.000 description 30
- 238000003860 storage Methods 0.000 description 26
- 150000002500 ions Chemical class 0.000 description 15
- 229920001864 tannin Polymers 0.000 description 11
- 235000018553 tannin Nutrition 0.000 description 11
- 239000001648 tannin Substances 0.000 description 11
- 238000007664 blowing Methods 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 239000000084 colloidal system Substances 0.000 description 6
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000002953 phosphate buffered saline Substances 0.000 description 6
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 5
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 4
- 108010088751 Albumins Proteins 0.000 description 4
- 102000009027 Albumins Human genes 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 238000010009 beating Methods 0.000 description 4
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 4
- 235000005487 catechin Nutrition 0.000 description 4
- 229950001002 cianidanol Drugs 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 230000006835 compression Effects 0.000 description 4
- 238000007906 compression Methods 0.000 description 4
- 210000002889 endothelial cell Anatomy 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 239000002064 nanoplatelet Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 238000001878 scanning electron micrograph Methods 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 238000003501 co-culture Methods 0.000 description 3
- 238000012669 compression test Methods 0.000 description 3
- 238000004945 emulsification Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 230000009818 osteogenic differentiation Effects 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 239000012296 anti-solvent Substances 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- NNMXSTWQJRPBJZ-UHFFFAOYSA-K europium(iii) chloride Chemical compound Cl[Eu](Cl)Cl NNMXSTWQJRPBJZ-UHFFFAOYSA-K 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000000411 inducer Substances 0.000 description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 2
- 239000011859 microparticle Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 239000011592 zinc chloride Substances 0.000 description 2
- 235000005074 zinc chloride Nutrition 0.000 description 2
- XDFNWJDGWJVGGN-UHFFFAOYSA-N 2-(2,7-dichloro-3,6-dihydroxy-9h-xanthen-9-yl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1C1C2=CC(Cl)=C(O)C=C2OC2=CC(O)=C(Cl)C=C21 XDFNWJDGWJVGGN-UHFFFAOYSA-N 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108010061711 Gliadin Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 108010060231 Insect Proteins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- 229940009456 adriamycin Drugs 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 229940126573 antibacterial therapeutic Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- DEGAKNSWVGKMLS-UHFFFAOYSA-N calcein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(O)=O)CC(O)=O)=C(O)C=C1OC1=C2C=C(CN(CC(O)=O)CC(=O)O)C(O)=C1 DEGAKNSWVGKMLS-UHFFFAOYSA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000001218 confocal laser scanning microscopy Methods 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 238000002242 deionisation method Methods 0.000 description 1
- 229940030275 epigallocatechin gallate Drugs 0.000 description 1
- GTSMOYLSFUBTMV-UHFFFAOYSA-N ethidium homodimer Chemical compound [H+].[H+].[Cl-].[Cl-].[Cl-].[Cl-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2C(C)=[N+]1CCCNCCNCCC[N+](C1=CC(N)=CC=C1C1=CC=C(N)C=C11)=C1C1=CC=CC=C1 GTSMOYLSFUBTMV-UHFFFAOYSA-N 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000010872 live dead assay kit Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000002103 nanocoating Substances 0.000 description 1
- 239000002114 nanocomposite Substances 0.000 description 1
- 229940031182 nanoparticles iron oxide Drugs 0.000 description 1
- 229960002378 oftasceine Drugs 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 230000002188 osteogenic effect Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0015—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0031—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/02—Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/046—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/06—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/08—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/08—Carbon ; Graphite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/10—Ceramics or glasses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/12—Phosphorus-containing materials, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2389/00—Characterised by the use of proteins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/34—Silicon-containing compounds
- C08K3/36—Silica
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/04—Oxygen-containing compounds
- C08K5/13—Phenols; Phenolates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/04—Oxygen-containing compounds
- C08K5/15—Heterocyclic compounds having oxygen in the ring
- C08K5/151—Heterocyclic compounds having oxygen in the ring having one oxygen atom in the ring
- C08K5/1545—Six-membered rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Ceramic Engineering (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention belongs to the field of material science and the field of biomedical materials, and particularly relates to an injectable colloidal gel material consisting of polyphenol and protein composite particles, and a preparation method and application thereof. The hydrogel material is formed by assembling through hydrophobic interaction and hydrogen bond interaction between polyphenol/protein composite micro-nano particles; the crosslinking among polyphenol/protein composite micro-nano particles can be realized by adding an oxidant to covalently crosslink among polyphenols; the polyphenol/protein composite micro-nano particles are formed by induced assembly through hydrogen bond action, hydrophobic action or electrostatic action between a protein polymer chain and polyphenol; and a crosslinking agent can be added to covalently crosslink protein chains to form stable micro-nano particles. The composite particles and the gel material thereof prepared by the invention have good stability, and can be used as drug sustained release carriers, tissue engineering scaffolds, tissue adhesion hemostatic materials and the like in the biomedical field.
Description
Technical Field
The invention belongs to the field of material science and the field of biomedical materials, and particularly relates to a gel material which is formed by compounding polyphenol and protein and consists of injectable and shapeable protein particles, and a preparation method and application thereof.
Background
The polymer micro-nano particles are a polymer material with special physical properties, and have the main characteristics of small particle size and high specific surface area. Based on the characteristics, the micro-nano particles are widely applied to microcarriers, micro separators and microreactors in the field of biomedicine. The micro-nano particles can be prepared by different manufacturing methods to obtain particle materials with expected shapes and sizes. In recent years, by controlling the interaction between particles, a gel material composed of particles can be obtained when close packing is formed between the particles. Due to the reversibility of the interaction between particles, the gel materials usually show the mechanical characteristics of shear thinning and self-repairing; meanwhile, due to the difference of the functionalities of different types of particles, micro-nano particles with different functions can be assembled to form a gel material with modular characteristics.
In the field of biomedical applications, protein materials are widely used because they generally have excellent biocompatibility. Micro-nano particles synthesized from various naturally occurring or engineered proteins have now become a promising platform for biomedical applications. In addition, the amphiphilic nature of the protein facilitates its interaction with hydrophilic and hydrophobic drugs and solvents. The large number of hydroxyl, amino and carboxyl groups present in them makes them susceptible to chemical modification. Thus, protein particles can be covalently or non-covalently linked to one or different types of ligands and drug molecules, which provides excellent surface modification properties. Over the past decades scientists have been using the biomedical potential of proteins, including gelatin, silk fibroin, albumin, gliadin and other substances from a wide variety of sources, such as animal, plant, insect and recombinant protein expression systems. However. The existing protein micro-nano particles are usually complex to prepare and low in yield. The protein material is prepared mainly by an anti-solvent method and an emulsion method. The preparation of nanoparticles by the anti-solvent method usually requires the addition of a large amount of organic reagents to cause protein to curl to form particles, and for the preparation of nanoparticles by the emulsion method, oil is usually required to be added as a surfactant, so that the separation process of oil and protein particles is very complicated. Therefore, it is important to use a simple and general protein particle preparation technical strategy to realize the mass production of protein nanoparticles.
Disclosure of Invention
The invention provides a colloidal particle hydrogel material compositely assembled by polyphenol and protein, which is formed by assembling through hydrophobic action and hydrogen bond action among polyphenol/protein composite micro-nano particles; preferably, after the hydrogel material is formed by assembling through hydrophobic interaction and hydrogen bond interaction between polyphenol/protein composite micro-nano particles, adding an oxidant to enable covalent crosslinking between polyphenols to realize crosslinking between polyphenol/protein composite micro-nano particles; the polyphenol/protein composite micro-nano particles are formed by induced assembly through hydrogen bond action, hydrophobic action or electrostatic action between a protein polymer chain and polyphenol; preferably, the polyphenol/protein composite micro-nano particles are formed by induced assembly through hydrogen bond interaction, hydrophobic interaction or electrostatic interaction between a protein polymer chain and polyphenol, and then the protein chain is covalently crosslinked by adding a crosslinking agent to form the stable micro-nano particles.
Wherein the size of the composite micro-nano particles is 10 nm-500 mu m, and when the size of the particles is 10 nm-5 mu m, the volume fraction of the composite micro-nano particles in the total volume of the hydrogel is 2-120 v/v%; when the particle size is 5-500 mu m, the volume fraction of the composite micro-nano particles in the granular hydrogel material accounting for the total volume of the hydrogel is 50-120 v/v%.
When the particle size is 10nm to 5 μm, the compressive elastic modulus of the hydrogel after covalent crosslinking is 0.5kPa to 500kPa;
when the particle size is 5 to 500. Mu.m, the compressive modulus of elasticity of the hydrogel after covalent crosslinking is 0.5kPa to 100kPa.
The invention provides a hydrogel material assembled by micro-nano colloidal particles compounded by polyphenol, protein and metal ions, wherein the hydrogel material is formed by assembling the polyphenol/protein compounded micro-nano colloidal particles under the hydrophobic action, the hydrogen bond action and the metal coordination action; preferably, after the hydrogel material is formed by assembling through hydrophobic interaction, hydrogen bond interaction and metal coordination between the polyphenol/protein composite micro-nano particles, an oxidant is added to enable covalent crosslinking between polyphenols to realize crosslinking between the polyphenol/protein composite micro-nano particles; the polyphenol/protein composite micro-nano particles are obtained by adding metal ions into the polyphenol/protein composite micro-nano particles to form coordination with polyphenol in the particles.
Wherein, the size of the composite microsphere particles is 10 nm-500 μm, when the size of the particles is 10 nm-5 μm, the volume fraction of the colloidal particles in the particle hydrogel material accounting for the total volume of the hydrogel is 2-120 v/v%, and the obtained particle hydrogel has the characteristics of shear thinning and self-repairing; the compression elastic modulus of the obtained granular hydrogel is 0.5 kPa-5 MPa.
When the particle size is 10nm to 5 μm, the compressive elastic modulus of the hydrogel after covalent crosslinking is 0.5kPa to 500kPa;
when the particle size is 5 to 500. Mu.m, the compressive modulus of elasticity of the hydrogel after covalent crosslinking is 0.5kPa to 100kPa.
The third aspect of the invention provides a hydrogel material assembled by rigid nanoparticle-polyphenol/protein composite core-shell structure micro/nano particles, wherein the hydrogel material is assembled by hydrophobic interaction and hydrogen bond interaction between the core-shell structure micro/nano particles; preferably, after the hydrogel material is formed by assembling through hydrophobic interaction and hydrogen bond interaction among the composite micro-nano colloidal particles, the crosslinking among the core-shell structure micro-nano particles is realized through covalent crosslinking among polyphenols by adding an oxidant; the core layer of the core-shell structure micro-nano particles is made of rigid nano particle materials, the shell layer is made of polyphenol/protein composite particles, and the polyphenol/protein composite particles are formed through hydrogen bond action, hydrophobic action and electrostatic action between protein molecules and polyphenol molecules; preferably, after the protein molecules and the polyphenol molecules are formed through hydrogen bond interaction, hydrophobic interaction and electrostatic interaction, a cross-linking agent is added to covalently cross-link protein chains to form the stable micro-nano particles.
Wherein, the size of the composite microsphere particles is 10 nm-500 μm, when the size of the particles is 10 nm-5 μm, the volume fraction of the colloidal particles in the particle hydrogel material accounting for the total volume of the hydrogel is 2-120 v/v%, and the obtained particle hydrogel has the characteristics of shear thinning and self-repairing; the compression elastic modulus of the obtained granular hydrogel is 0.5 kPa-5 MPa.
When the particle size is 10nm to 5 μm, the compressive elastic modulus of the hydrogel after covalent crosslinking is 0.5kPa to 500kPa;
when the particle size is 5 to 500. Mu.m, the compressive modulus of elasticity of the hydrogel after covalent crosslinking is 0.5kPa to 100kPa.
The invention provides a core-shell structure colloidal particle material compounded by rigid nano particles, polyphenol/protein/metal ions, wherein the hydrogel material is formed by assembling hydrophobic interaction, hydrogen bond interaction and metal coordination interaction among the micro-nano particles with the core-shell structure; preferably, after the hydrogel material is formed by assembling through hydrophobic interaction, hydrogen bond interaction and metal coordination interaction between the core-shell structure micro-nano particles, an oxidant is added to enable covalent crosslinking between polyphenols to realize crosslinking between the core-shell structure micro-nano particles; the core layer of the core-shell structure micro-nano particle is made of rigid nano particle materials, the shell layer is made of polyphenol/protein/metal composite particles, and the polyphenol/protein/metal composite particles are obtained by adding metal ions into the polyphenol/protein composite particles of claim 3 to form coordination with polyphenol in the particles.
Wherein, the size of the composite microsphere particles is 10 nm-500 μm, when the size of the particles is 10 nm-5 μm, the volume fraction of the colloidal particles in the particle hydrogel material accounting for the total volume of the hydrogel is 2-120 v/v%, and the obtained particle hydrogel has the characteristics of shear thinning and self-repairing; the compression elastic modulus of the obtained granular hydrogel is 0.5 kPa-5 MPa.
When the particle size is 10nm to 5 μm, the compressive elastic modulus of the hydrogel after covalent crosslinking is 0.5kPa to 500kPa;
when the particle size is 5 to 500. Mu.m, the compressive elastic modulus of the hydrogel after covalent crosslinking is 0.5kPa to 100kPa.
In the above-mentioned technical solution, further,
the polyphenol material is selected from one or more of gallic acid, gallate, epigallocatechin, quercetin, curcumin, tannic acid, catechol, and dopamine;
the protein material is selected from pure structural protein, pure structural protein derivatives, pure structural protein and hydrophilic polymer material mixture; the pure structural protein is gelatin protein, sericin, silk fibroin, albumin, serum protein, keratin, elastin, hemoglobin, immunoglobulin, fibrin, fluorescent protein GFP;
the oxidant in the polyphenol oxidation process is sodium dichromate, potassium permanganate, sodium periodate, sodium peroxide, potassium peroxide and hydrogen peroxide;
the metal ions used for the coordination interaction of the metal ions are one or more of aluminum, vanadium, chromium, manganese, iron, cobalt, nickel, copper, zinc, zirconium, molybdenum, ruthenium, rhodium, cadmium, cerium, europium, gadolinium and terbium ions;
the rigid nanoparticles are silica nanoparticles, lithium magnesium silicate nanoparticles, nanoclay particles, hydroxyapatite nanoparticles, iron oxide magnetic nanoparticles, barium titanate nanoparticles, graphene nanosheets, carbon nanotubes, bioglass nanoparticles, black phosphorus nanosheets, silk fibroin nanoparticles, polylactic acid nanoparticles, polyethylene nanoparticles, polystyrene nanoparticles;
when the size of the composite micro-nano particles is 10 nm-5 mu m, the volume fraction of the composite micro-nano particles in the total volume of the hydrogel is 2-120 v/v%; when the size of the composite micro-nano particles is 5-500 mu m, the volume fraction of the composite micro-nano particles in the total volume of the hydrogel is 50-120 v/v%.
In the above technical solution, further, the preparation method of the micro-nano particle hydrogel material assembled by polyphenol and protein comprises the following preparation steps:
(1) Dissolving protein in aqueous solution at 10-80 deg.c to obtain 0.1-10 w/v% concentration protein solution; dissolving polyphenol in water solution at 10-90 deg.c to obtain polyphenol water solution in the concentration of 0.1-10 w/v%;
(2) Adjusting the pH value of the protein solution to 3-7, adding a polyphenol solution into the protein solution to obtain a protein/polyphenol composite particle solution, and freeze-drying to obtain composite particle powder; wherein the mass ratio of the protein to the polyphenol is 0.1-20, preferably 1-20; preferably, adding a macromolecular cross-linking agent into the protein/polyphenol composite particle solution at normal temperature to stabilize the composite particles for reaction for 1-12 hrs, wherein the mass ratio of the protein to the macromolecular cross-linking agent is 0.1-100; cleaning to obtain a protein/polyphenol composite particle dispersion liquid, and freeze-drying the particle dispersion liquid to obtain composite particle powder;
(3) Mixing the protein/polyphenol composite particle powder with an aqueous solution to obtain an injectable self-repairing colloidal gel; preferably, the injectable and self-repairing colloidal gel is further added with an oxidant to polymerize polyphenol on the surfaces of the composite particles to obtain a crosslinked colloidal hydrogel;
in the step (2), the cross-linking agent is one or more of carbodiimide/N-hydroxysuccinimide, formaldehyde, acetaldehyde, glyceraldehyde, aromatic dialdehyde, glutaraldehyde, succinaldehyde, genipin, diglycidyl ether, di-alkylene oxide, divinyl sulfones, polyfunctional aziridine and diisocyanate;
in the step (3), the oxidant is sodium dichromate, potassium permanganate, sodium periodate, sodium peroxide, potassium peroxide and hydrogen peroxide;
preferably, the aqueous solution is water or an aqueous solution blended with other substances; the other substances are one or more of vitamins, amino acids, mineral elements, microecological regulators, silicon dioxide nanoparticles, lithium magnesium silicate nanoparticles, nano clay particles, hydroxyapatite nanoparticles, iron oxide magnetic nanoparticles, barium titanate nanoparticles, graphene nanosheets, carbon nanotubes, bioglass nanoparticles, black phosphorus nanosheets, silk fibroin nanoparticles, polylactic acid nanoparticles, polyethylene nanoparticles, polystyrene nanoparticles, alginic acid, hyaluronic acid, chitosan, chondroitin sulfate, pullulan, xanthan gum and starch.
In the above technical solution, further, the preparation method of the colloidal particle hydrogel material assembled by the polyphenol, the protein and the metal ions is characterized in that:
(1) Dissolving protein in aqueous solution at 10-80 deg.c to obtain 0.1-10 w/v% concentration protein solution; dissolving polyphenol in aqueous solution at 10-90 ℃ to obtain polyphenol aqueous solution with the concentration of 0.1-10 w/v%;
(2) Adjusting the pH value of the protein solution to 3-7, and adding a polyphenol solution into the protein solution to obtain a protein/polyphenol composite particle solution, wherein the mass ratio of the protein to the polyphenol is 0.1-20, preferably 1-20; adding metal ions into the particle solution, stirring to obtain a particle dispersion liquid, wherein the concentration of the metal ions is 1 mM-10M, centrifuging, washing and freeze-drying the particle dispersion liquid to obtain composite particle powder. Preferably, the particle solution is added with a macromolecular cross-linking agent at normal temperature to stabilize the composite particles, and then metal ions are added after the composite particles react for 1 to 12hrs, wherein the mass ratio of the protein to the macromolecular cross-linking agent is 0.1 to 100;
(3) Mixing the protein/polyphenol composite particle powder with an aqueous solution to obtain an injectable self-repairing colloidal gel; preferably, the injectable and self-repairing colloidal gel is further added with an oxidation cross-linking agent to polymerize polyphenol on the surfaces of the composite particles to obtain a cross-linked colloidal hydrogel;
in the step (2), the cross-linking agent is one or more of carbodiimide/N-hydroxysuccinimide, formaldehyde, acetaldehyde, glyceraldehyde, aromatic aldehyde, glutaraldehyde, succinaldehyde, genipin, diglycidyl ether, dialkene oxide, divinyl sulfone, polyfunctional aziridine and diisocyanate;
in the step (3), the oxidative crosslinking agent is sodium dichromate, potassium permanganate, sodium periodate, sodium peroxide, potassium peroxide and hydrogen peroxide; the metal ions used for the coordination crosslinking of the metal ions are one or more of aluminum, vanadium, chromium, manganese, iron, cobalt, nickel, copper, zinc, zirconium, molybdenum, ruthenium, rhodium, cadmium, cerium, europium, gadolinium and terbium ions;
preferably, the aqueous solution is water or an aqueous solution blended with other substances; the other substances are one or more of vitamins, amino acids, mineral elements, microecological regulators, silicon dioxide nanoparticles, lithium magnesium silicate nanoparticles, nano clay particles, hydroxyapatite nanoparticles, iron oxide magnetic nanoparticles, barium titanate nanoparticles, graphene nanosheets, carbon nanotubes, bioglass nanoparticles, black phosphorus nanosheets, silk fibroin nanoparticles, polylactic acid nanoparticles, polyethylene nanoparticles, polystyrene nanoparticles, alginic acid, hyaluronic acid, chitosan, chondroitin sulfate, pullulan, xanthan gum and starch.
In the above technical solution, further, the preparation method of the core-shell structure colloidal particle material of the nanoparticle-polyphenol composite protein molecule is characterized in that the composite particle comprises the following preparation steps:
(1) Dissolving protein molecules in an aqueous solution at 10-80 ℃ to obtain a protein aqueous solution with the concentration of 0.1-10 w/v%; dissolving polyphenol in aqueous solution at 10-90 deg.c to obtain polyphenol water solution with concentration of 0.1-10 w/v%;
(2) Adding rigid nano particles into the protein aqueous solution, adjusting the pH value of the solution to 3-7, and adding a polyphenol solution to obtain a core-shell structure composite particle solution; freeze drying to obtain composite particle powder; wherein the mass ratio of the protein to the polyphenol is 0.1-20, and the mass ratio of the protein to the rigid nano particles is 0.1-30; preferably, at normal temperature, adding a cross-linking agent into the composite particle solution for further cross-linking and stabilizing the composite particles for reaction for 1-12 h, wherein the mass ratio of the protein to the macromolecular cross-linking agent is 0.1-100; (ii) a Cleaning to obtain a composite particle dispersion liquid of protein/polyphenol/nanoparticles, and freeze-drying the particle dispersion liquid to obtain composite particle powder;
(3) The composite particle powder and the aqueous solution are blended to obtain injectable self-repairing colloidal gel; preferably, the injectable self-repairing colloidal gel further comprises an oxidative crosslinking agent or metal ions to polymerize the polyphenol on the surface of the composite particles to obtain a crosslinked colloidal hydrogel;
in the step (2), the cross-linking agent is one or more of carbodiimide/N-hydroxysuccinimide, formaldehyde, acetaldehyde, glyceraldehyde, aromatic aldehyde, glutaraldehyde, succinaldehyde, genipin, diglycidyl ether, dialkene oxide, divinyl sulfone, polyfunctional aziridine and diisocyanate; the rigid nanoparticles may be silica nanoparticles, lithium magnesium silicate nanoparticles, nanoclay particles, hydroxyapatite nanoparticles, iron oxide magnetic nanoparticles, barium titanate nanoparticles, graphene nanoplatelets, carbon nanotubes, bioglass nanoparticles, black phosphorus nanoplatelets, silk fibroin nanoparticles, polylactic acid nanoparticles, polyethylene nanoparticles, polystyrene nanoparticles;
in the step (3), the oxidation crosslinking agent is sodium dichromate, potassium permanganate, sodium periodate, sodium peroxide, potassium peroxide and hydrogen peroxide; the metal ions used for the coordination crosslinking of the metal ions are one or more of aluminum, vanadium, chromium, manganese, iron, cobalt, nickel, copper, zinc, zirconium, molybdenum, ruthenium, rhodium, cadmium, cerium, europium, gadolinium and terbium ions;
preferably, the aqueous solution is water or an aqueous solution blended with other substances; the other substances are one or more of vitamins, amino acids, mineral elements, microecological regulators, silicon dioxide nanoparticles, lithium magnesium silicate nanoparticles, nano clay particles, hydroxyapatite nanoparticles, iron oxide magnetic nanoparticles, barium titanate nanoparticles, graphene nanosheets, carbon nanotubes, bioglass nanoparticles, black phosphorus nanosheets, silk fibroin nanoparticles, polylactic acid nanoparticles, polyethylene nanoparticles, polystyrene nanoparticles, alginic acid, hyaluronic acid, chitosan, chondroitin sulfate, pullulan, xanthan gum and starch.
In the above technical solution, further, the preparation method of the core-shell structure colloidal particle material of nanoparticles-polyphenol, protein and metal molecule is characterized in that the composite particle comprises the following preparation steps:
(1) Dissolving protein molecules in an aqueous solution at 10-80 ℃ to obtain a protein aqueous solution with the concentration of 0.1-10 w/v%; dissolving polyphenol in aqueous solution at 10-90 deg.c to obtain polyphenol water solution with concentration of 0.1-10 w/v%;
(2) Adding rigid nano particles into the protein aqueous solution, adjusting the pH value of the solution to 3-7, and adding a polyphenol solution to obtain a core-shell structure composite particle solution; wherein the mass ratio of the protein to the polyphenol is 0.1-20, and the mass ratio of the protein to the hard nano-particles is 0.1-30; adding metal ions into the particle dispersion liquid, stirring, centrifuging, washing and freeze-drying the particle dispersion liquid to obtain composite particle powder, wherein the concentration of the metal ions is 1 mM-10M; preferably, at normal temperature, adding a cross-linking agent into the core-shell structure composite particle solution for further cross-linking and stabilizing the composite particles for reaction for 1-12 h, wherein the mass ratio of the protein to the macromolecular cross-linking agent is 0.1-100; cleaning to obtain a composite particle dispersion liquid of protein/polyphenol/nanoparticles;
(3) The composite particle powder and the aqueous solution are blended to obtain injectable self-repairing colloidal gel; preferably, the injectable self-repairing colloidal gel further comprises an oxidative crosslinking agent or metal ions to polymerize the polyphenol on the surface of the composite particles, so as to obtain a crosslinked colloidal hydrogel;
in the step (2), the cross-linking agent is one or more of carbodiimide/N-hydroxysuccinimide, formaldehyde, acetaldehyde, glyceraldehyde, aromatic aldehyde, glutaraldehyde, succinaldehyde, genipin, diglycidyl ether, dialkene oxide, divinyl sulfone, polyfunctional aziridine and diisocyanate; the nanoparticles may be silica nanoparticles, lithium magnesium silicate nanoparticles, nanoclay particles, hydroxyapatite nanoparticles, iron oxide magnetic nanoparticles, barium titanate nanoparticles, graphene nanoplatelets, carbon nanotubes, bioglass nanoparticles, black phosphorus nanoplatelets, silk fibroin nanoparticles, polylactic acid nanoparticles, polyethylene nanoparticles, polystyrene nanoparticles;
in the step (3), the oxidation crosslinking agent is sodium dichromate, potassium permanganate, sodium periodate, sodium peroxide, potassium peroxide and hydrogen peroxide; the metal ions used by the metal ion coordination crosslinking are one or more of aluminum, vanadium, chromium, manganese, iron, cobalt, nickel, copper, zinc, zirconium, molybdenum, ruthenium, rhodium, cadmium, cerium, europium, gadolinium and terbium ions;
preferably, the aqueous solution is water or an aqueous solution blended with other substances; the other substances are one or more of vitamins, amino acids, mineral elements, microecological regulators, silicon dioxide nanoparticles, lithium magnesium silicate nanoparticles, nano clay particles, hydroxyapatite nanoparticles, iron oxide magnetic nanoparticles, barium titanate nanoparticles, graphene nanosheets, carbon nanotubes, bioglass nanoparticles, black phosphorus nanosheets, silk fibroin nanoparticles, polylactic acid nanoparticles, polyethylene nanoparticles, polystyrene nanoparticles, alginic acid, hyaluronic acid, chitosan, chondroitin sulfate, pullulan, xanthan gum and starch.
In a fifth aspect, the present invention provides the use of the hydrogel material as described above, wherein the use comprises the following aspects:
the application of the compound granules in preparing anti-inflammatory, antioxidant and antibacterial scaffolds can slowly release polyphenol in the compound granules, and the scaffolds are used for repairing and filling wounds or defects of bone tissues, cartilage tissues, muscles, blood vessels and skin;
or in the preparation of a carrier or a bracket containing medicinal components, wherein the medicinal components are one or more of vitamins, amino acids, mineral elements, microecological regulators, growth factors, micromolecular medicaments, protein macromolecular medicaments, antibiotic medicaments, hormone medicaments, anesthetic medicaments, antiviral medicaments, antibacterial medicaments, anticancer medicaments, immunoregulation medicaments, nucleic acid medicaments or live cells;
or the application in preparing superficial skin and subcutaneous filler; preferably in cosmetic surgery; when the gel is applied, the gel is directly injected into superficial skin or subcutaneous region, a small amount of oxidant or metal ions are mixed, colloidal particle gel can be reversibly self-assembled under the action of non-covalent bonds to form a continuous porous particle network, the continuous porous particle network can stably stay at the injection position, the particle surface is further subjected to secondary crosslinking, the gel stability is improved, and the filling stability is ensured.
Or in the preparation of bio-inks, preferably bio-printing inks for printing with living cells; when the method is applied, colloidal particles and an aqueous solution are blended to obtain colloidal particle gel, then the colloidal particle gel is mixed with a cell suspension to obtain cell-loaded colloidal gel, namely biological ink, and the ink is extruded or subjected to ink-jet 3D printing to obtain a scaffold with a 3D structure, so that a cell-loaded printing scaffold is obtained;
or in the preparation of tissue adhesive gel material, wherein the composite microsphere particle size is less than 10 μm, and the adhesive strength between the colloidal gel and the tissue is 5-100 kPa; injecting the colloid gel material with injectable and self-repairing performance to the damaged part of the tissue in the body, and waiting for 1-30 min to realize the stable adhesion between the colloid gel and the tissue.
Or in the preparation of metal ion slow release carrier, used for wound tissue repair and anti-infection;
or the quick hemostasis sealing powder is applied to the quick hemostasis sealing powder, the quick hemostasis sealing powder comprises the prepared composite microsphere particle powder, the particle powder is directly sprayed to the wound surface defect position of the tissue surface, and after the powder fully absorbs exuded blood, the powder can form an adhesion effect with the tissue and realize effective hemostasis.
The invention has the beneficial effects that:
1. the invention discloses a preparation method of protein micro-nano particles with universality. The method dissolves protein materials in aqueous solution to be compounded with the aqueous solution containing polyphenol, and polyphenol can be rapidly combined with protein through hydrogen bond, hydrophobic interaction and electrostatic interaction to form polyphenol protein network, so that the polyphenol protein composite particle material is formed. The preparation method of the protein particles does not need to use organic reagents or surfactants used in the traditional protein particle preparation process, and only utilizes the strong interaction between polyphenol and protein to realize particle synthesis. This greatly reduces the production cost of the protein particles.
2. The preparation method of the protein particles is suitable for different kinds of protein materials. Since polyphenols can form interactions with different types of proteins, the method reported in the present invention can be used to prepare different types of protein particles. The general applicability of the current methods greatly expands protein particle manufacturing techniques, and in part particle manufacturing of difficult-to-granulate protein materials, as compared to conventional protein particle manufacturing techniques, which are typically directed only to a particular protein material.
3. The protein micro-nano particles reported by the invention are assembled to form a gel material with shear thinning and self-repairing performances through a reversible action; because the protein particles also contain polyphenol components, the abundant phenolic hydroxyl units in the polyphenol can form stable interaction with the tissue surface. Therefore, the particulate gel material reported by the invention has stable tissue adhesion and can be used as a tissue adhesion material for wound repair.
4. The protein micro-nano particles reported by the invention contain abundant phenolic hydroxyl groups, and can be coordinated and compounded with different types of metal ions to quickly realize the quick preparation of micro-nano particle units with different functions. Protein particles with different functions can be modularly assembled to form gel materials with different functions.
5. The composite particles reported in the present invention can also be used as therapeutic ingredients for antioxidant, anti-inflammatory and antibacterial therapeutic applications. Meanwhile, polyphenol is a common hemostatic material, so the colloidal gel prepared by the method has hemostatic and tissue adhesion properties.
Drawings
FIG. 1 is a scanning electron micrograph of a metal ion-complexed gelatin/tannic acid colloidal gel prepared in example 5; wherein purple in the Cu complex group represents Cu ions; yellow in the Fe complex group represents Fe ions; 3, orange color in the Zn complex group represents Zn ions; purple color in the Ce complex represents Ce ion.
FIG. 2 is a scanning electron micrograph of a covalently cross-linked gelatin/tannic acid colloidal gel prepared according to example 7, wherein panel b is an enlarged view of panel a.
Fig. 3 is a transmission electron microscope image of composite particles of the silica core-gelatin/polyphenol shell structure prepared in example 8.
Figure 4 is a graph of the release of polyphenols from the colloidal gel of example 17.
FIG. 5 is a two-dimensional cell culture dead-live staining pattern of the colloidal gel material obtained in example 18, and the survival condition of the cells on the surface of the gel is good, indicating that the colloidal gel has excellent biocompatibility. Wherein the ruler is 50 μm.
FIG. 6 is a graph showing the bacteriostatic test of the colloidal gel obtained in example 19. Wherein the yellow pure gelatin colloid gel in the A picture normally grows bacteria, the gel in the B picture is gelatin/tannin composite colloid gel, and no bacteria growth around the gel indicates that the gel has bacteriostasis.
FIG. 7 is a graph showing the colloidal gel of example 20 as a drug sustained-release carrier. Different kinds of protein drugs can be slowly released within 21 days.
FIG. 8 is a photograph of the cells of Ce ion composite colloidal gel against oxidation in example 21, in which the green signal represents active oxygen DCFH and the red signal represents active oxygen Ru (dpp) Cl 2 。
FIG. 9 is a photograph showing the staining of osteogenic factor alkaline phosphatase after co-culturing Zn ion complex colloidal gel with osteoblasts MC-3T3 in example 21, wherein the bluish purple signal represents the signal of alkaline phosphatase.
FIG. 10 is a photograph showing the co-culture of the Cu ion composite colloidal gel and endothelial cells in example 23.
Figure 11 is a sample picture of the colloidal gel 3D printed stent of example 22.
Detailed Description
The invention is further illustrated but is not in any way limited by the following specific examples.
Example 1
A gelatin solution was obtained by dissolving 5g of gelatin powder in 100mL of deionized water at 50 ℃ and adjusting the pH to 3, 5 and 7, and a tannic acid solution was obtained by dissolving 0.5g of tannic acid powder in 100mL of deionized water at 50 ℃. 100mL of tannic acid solution was slowly added to the gelatin solution over 30min and the solution was stirred at 1500rpm to rapidly bind the protein to the tannic acid molecules to form particles. Then 165. Mu.L of glutaraldehyde, a crosslinking agent, was added and stirred for 12hrs. And (3) cleaning the composite particles by using deionized water, and freeze-drying the composite particles to obtain gelatin/tannic acid nano-particle powder. The size and charge of the resulting nanoparticles are shown in table 1.
TABLE 1
Particle size | Surface charge | |
pH=3 | 214.6nm | -14.7mV |
pH=5 | 239.5nm | -10.9mV |
pH=7 | 306.5nm | -6.1mV |
Repeatedly blowing and beating 0.3g of gelatin/tannic acid nano-particle powder and 1mL of deionized water for 10 times through a luer adapter injector at normal temperature to obtain the injectable self-repairing composite particle gel. The gel was tested for storage modulus G' using a time-sweep mode of a rotational rheometer and the self-healing efficiency is shown in table 2. Where the frequency was 1Hz and the strain was 0.5%. The data in table 2 shows that as the mass fraction of particles increases, the storage modulus of the gel formed increases and the gel has self-healing properties.
TABLE 2
Storage modulus | Self-repair efficiency | |
pH=3 | 8.9kPa | 73.1% |
pH=5 | 9.7kPa | 75.2% |
pH=7 | 7.2kPa | 79.7% |
Comparative example 1
5g of gelatin powder was dissolved in 100mL of deionized water at 50 ℃ to give a gelatin solution and the pH was adjusted to 9, 11. 0.5g of tannic acid powder was dissolved in 100mL of deionized water at 50 ℃ to obtain a tannic acid solution. The 100mL tannic acid solution is added into a gelatin solution within 30min, the color of the solution is brown and clear, and the particle size in the solution is further tested to show that micro-nano particles are not formed in the test.
Comparative example 2
A gelatin solution was obtained by dissolving 5g of gelatin powder in 100mL of deionized water at 50 ℃ and adjusting the pH to 3, 5 and 7, and a tannic acid solution was obtained by dissolving 0.5g of tannic acid powder in 100mL of deionized water at 50 ℃. 100mL of gelatin solution was slowly added to the tannic acid solution over 30min, whereupon a brown flocculent precipitate formed, which failed to give an emulsified particle suspension.
Example 2
A gelatin solution was obtained by dissolving 5g of gelatin powder in 100mL of deionized water at 50 ℃ and adjusting the pH to 3, 5 and 7, and a tannic acid solution was obtained by dissolving 0.5g of tannic acid powder in 100mL of deionized water at 50 ℃. 100mL of tannic acid solution was slowly added to the gelatin solution over 30min and the solution was stirred at 1500rpm to rapidly bind the protein to the tannic acid molecules to form particles. And (3) cleaning the composite particles by using deionized water, and freeze-drying the composite particles to obtain gelatin/tannic acid nano-particle powder. The size and charge of the resulting nanoparticles are shown in table 3.
TABLE 3
Particle size | Surface charge | |
pH=3 | 331.9nm | -3.7mV |
pH=5 | 409.7nm | -5.9mV |
pH=7 | 426.9nm | -4.3mV |
Repeatedly blowing and beating 0.3g of gelatin/tannic acid nano-particle powder and 1mL of deionized water for 10 times through a luer adapter injector at normal temperature to obtain the injectable self-repairing composite particle gel. The gel was tested for storage modulus G' using a time-sweep mode of a rotational rheometer and the self-healing efficiency is shown in table 3. Where the frequency was 1Hz and the strain was 0.5%. The data in table 4 shows that as the mass fraction of particles increases, the storage modulus of the formed gel increases and the gel has self-healing properties.
TABLE 4
Storage modulus | Efficiency of self-repair | |
pH=3 | 6.2kPa | 88.1% |
pH=5 | 4.7kPa | 94.6% |
pH=7 | 4.5kPa | 95.4% |
Example 3
5g of gelatin powder was dissolved in 100mL of deionized water at 50 ℃ to give a gelatin solution and the pH was adjusted to 5. 0.25, 0.5, 2, 5g of tannic acid powder was dissolved in 100mL of deionized water at 50 ℃ to obtain a tannic acid solution. The above 100mL tannic acid solution was added to the gelatin solution within 30min and stirred at 1500rpm to bind protein molecules and tannic acid molecules into particles. 165. Mu.L of glutaraldehyde, a crosslinking agent, was then added and stirred for 12hrs. And cleaning the composite particles by using deionized water, and freeze-drying the composite particles to obtain composite particle powder. The size and charge of the resulting composite particles are shown in table 5.
TABLE 5
Tannic acid/gelatin (w/w) | Particle size | Surface charge |
0.05 | 254.6nm | -12.7mV |
0.1 | 219.5nm | -16.9mV |
0.4 | 116.5nm | -23.1 |
1 | 85.6nm | -33.5mV |
Repeatedly blowing and beating 0.3g of gelatin/tannic acid composite particle powder and 1mL of deionized water for 10 times through a luer adapter injector at normal temperature to obtain the injectable self-repairing particle gel. The storage modulus G' of the particle gel was obtained using the time-scan mode of the rotational rheometer and the self-healing efficiency is shown in table 6. Where the frequency was 1Hz and the strain was 0.5%. Rheological experiments show that the highest storage modulus is shown when the ratio of the tannic acid to the gelatin is 0.1, and the highest self-repairing efficiency is shown when the ratio of the tannic acid to the gelatin is 1.
TABLE 6
Tannic acid/gelatin (w/w) | Storage modulus | Efficiency of self-repair |
0.05 | 6.9kPa | 73.5% |
0.1 | 7.6kPa | 76.9% |
0.4 | 5.5kPa | 83.9% |
1 | 4.9kPa | 89.4% |
Comparative example 3
5g of gelatin powder was dissolved in 100mL of deionized water at 50 ℃ to give a gelatin solution and the pH was adjusted to 5. 0.1g of tannic acid powder was dissolved in 100mL of deionized water at 50 ℃ to obtain a tannic acid solution. Adding the 100mL tannic acid solution into gelatin solution within 30min, and stirring at 1500rpm, wherein the solution is transparent and clear, and no emulsification occurs. Further testing the particle size in the solution shows that no micro-nano particles are formed in the test, which indicates that the gelatin/tannic acid mass ratio is too low to form nano particles at 0.02.
5g of gelatin powder was dissolved in 100mL of deionized water at 50 ℃ to give a gelatin solution and the pH was adjusted to 5. A tannic acid solution was obtained by dissolving 150g of tannic acid powder in 100mL of deionized water at 50 ℃. When the above 100mL of tannic acid solution was added to the gelatin solution within 30min and stirred at 1500rpm, a brown precipitate was rapidly produced, indicating that the tannic acid mass ratio of 30 resulted in agglomeration of particles and failure to obtain a dispersed particulate material.
Example 4
5g of gelatin powder was dissolved in 100mL of deionized water at 50 ℃ to give a gelatin solution and the pH was adjusted to 5. Respectively dissolving 0.5g EGCG (epigallocatechin gallate), gallic acid, quercetin and catechin powder in 100mL deionized water at 50 deg.C to obtain corresponding polyphenol solution. Adding the polyphenol solutions into the gelatin solution within 30min, and rapidly stirring to combine gelatin molecules with different polyphenols to form micro-nano particles. 165. Mu.L of glutaraldehyde, a crosslinking agent, was then added and stirred for 12hrs. And (3) cleaning the composite particles by using deionized water, and freeze-drying the composite particles to obtain different polyphenol and gelatin composite nano-particle powder. The size and charge of the resulting nanoparticles are shown in table 7.
TABLE 7
Type of particle | Particle size | Surface charge |
EGCG/gelatin | 317.9nm | -17.7mV |
Gallic acid/gelatin | 313.9nm | -13.9mV |
Quercetin/gelatin | 269.4nm | -19.8mV |
Catechin/gelatin | 295.7nm | -9.3mV |
Repeatedly blowing and beating 0.3g of EGCG/gelatin, gallic acid/gelatin, quercetin/gelatin and catechin/gelatin nano-particle powder and 1mL of deionized water for 10 times through a luer adapter injector at normal temperature to obtain the injectable self-repairing particle gel. The storage modulus G' of the particulate gel was obtained using the time-sweep mode of the rotational rheometer and the self-healing efficiency is shown in table 8. Where the frequency was 1Hz and the strain was 0.5%. Rheological experiments show that the use of different kinds of polyphenol materials has no obvious influence on the storage modulus and the self-repairing performance of the final gel.
TABLE 8
Type of particle | Storage modulus | Self-repair efficiency |
EGCG/gelatin | 6.3kPa | 81.3% |
Gallic acid/gelatin | 7.1kPa | 75.9% |
Quercetin/gelatin | 7.2kPa | 78.9% |
Catechin/gelatin | 5.9kPa | 74.2% |
Example 5
5g of sericin, silk fibroin, albumin, serum protein, keratin, elastin, hemoglobin, immunoglobulin, fibrin, fluorescent protein GFP and gelatin derivative methacrylate gelatin were dissolved in 100mL of deionized water at 37 ℃ to obtain a protein solution and pH was adjusted to 5. 0.5g of tannic acid powder was dissolved in 100mL of deionized water at 50 ℃ to obtain a tannic acid solution. Adding the above 100mL tannic acid solution within 30min, stirring rapidly, combining with the tannic acid molecules using fibroin molecules to form nanoscale spheres, and stirring for 12hrs. And (3) washing the nano particles by using deionized water, and freeze-drying the nano particles to obtain fibroin/tannin nano particle powder. The size and charge of the resulting nanoparticles are shown in table 9.
TABLE 9
Protein species | Particle size | Surface charge |
Sericin | 227.8nm | -27.7mV |
Silk fibroin | 279.2nm | -31.3mV |
Albumin | 173.4nm | -17.2mV |
Serum protein | 149.0nm | -19.2mV |
Keratin protein | 219.3nm | -9.2mV |
Elastin | 293.5nm | -4.7mV |
Hemoglobin | 102.2nm | 5.8mV |
Immunoglobulins | 52.3nm | -7.2mV |
Fibrin | 71.2nm | -12.8mV |
Fluorescent proteins | 49.2nm | 2.9mV |
Gelatin methacrylate | 284.5nm | -17.9mV |
Repeatedly blowing 0.4g of silk fibroin/tannin, albumin/tannin, keratin/tannin, fluorescent protein/tannin particle powder and 1mL of deionized water through a luer adapter injector at normal temperature for 10 times to obtain the injectable self-repairing particle gel. The storage modulus G' of the particulate gel was obtained using the time-sweep mode of the rotational rheometer as shown in table 4. Where the frequency was 1Hz and the strain was 0.5%. Different types of proteins showed different mechanical strengths after complexing with tannic acid as shown in table 10.
Protein type | Storage modulus |
Silk fibroin | 28.6kPa |
Albumin | 14.1kPa |
Keratin protein | 11.2kPa |
Fluorescent proteins | 7.9kPa |
Gelatin methacrylate | 12.9kPa |
Example 6
5g of gelatin powder was dissolved in 100mL of deionized water at 50 ℃ and pH was adjusted to 5, and 0.5g of tannic acid powder was dissolved in 100mL of deionized water at 50 ℃ to obtain a tannic acid solution. Adding the 100mL of tannic acid solution into the gelatin solution within 30min, and rapidly stirring to combine the gelatin and tannic acid to form micro-nano composite particles. 165. Mu.L of glutaraldehyde, a crosslinking agent, was then added and stirred for 12hrs. After the composite particles are washed by deionized water, the concentration of the particles is diluted to 10mg/mL by the deionized water, copper chloride, ferric chloride, zinc chloride and europium chloride are respectively added into the solution until the final solution concentration reaches 10mM, the mixture is stirred for 12hrs, and the composite particles are repeatedly washed by the deionized water for 3 times, so that the metal composite protein particles are obtained. The size and charge of the obtained nanoparticles are shown in table 11, wherein the scanning electron micrograph of the particles is shown in fig. 1, and the corresponding metal elements have been successfully compounded in the particles.
TABLE 11
Chelating metal ion species | Particle size | Surface charge |
Cu | 214.6nm | -14.7mV |
Fe | 235.9nm | -19.3mV |
Zn | 275.1nm | -21.3mV |
Ce | 224.7nm | -19.2mV |
Repeatedly blowing 0.4g of different metal ion chelating protein/polyphenol nanoparticle powder and 1mL of deionized water for 10 times through a luer adapter injector at normal temperature to obtain the injectable self-repairing particle gel. The storage modulus G' of the particulate gel was obtained using a time-sweep mode of a rotational rheometer, and the self-healing efficiency is shown in table 12. Where the frequency was 1Hz and the strain was 0.5%. In comparison with example 1, it can be seen that the mechanical strength of the gel is significantly increased when the surface of the particles is chelated by the metal ions.
TABLE 12
Type of metal | Storage modulus |
Cu | 28.6kPa |
Fe | 24.1kPa |
Zn | 21.2kPa |
Ce | 17.9kPa |
Example 7
Using the gelatin/tannic acid micro-nano particle powder prepared in example 1 (pH 5), 0.4g of the particle powder was repeatedly blown and beaten with 5mg of sodium periodate, sodium dichromate, sodium peroxide, hydrogen peroxide, and 1mL of deionized water at normal temperature through a luer adapter syringe for 10 times to obtain injectable particle gel. The storage modulus G' of the particulate gel was measured using a time-sweep mode of a rotational rheometer and the self-healing efficiency is shown in table 13. Where the frequency was 1Hz and the strain was 0.5%. The composite particulate gel can be further enhanced because the oxidative crosslinking agent induces covalent crosslinking of the tannin molecules on the surface of the particles. Where the frequency was 1Hz and the strain was 0.5%. The storage modulus of the uncrosslinked gelatin/tannic acid nanoparticles of comparative example 1 was obtained, and the mechanical strength of the same mass fraction gel was significantly improved when the oxidative crosslinking agent was added. The microstructure of the covalently cross-linked gel is shown in the scanning electron micrograph of FIG. 2.
Watch 13
Example 8
Dissolving 5g of gelatin powder in 100mL of deionized water at 50 ℃, adjusting the pH value of the solution to 5, and respectively adding 1g of silicon dioxide nanoparticles, graphene nanosheets, hydroxyapatite nanoparticles, fibroin nanoparticles and bioglass nanoparticle powder to obtain the gelatin solution containing nanoparticles. 0.5g of tannic acid powder was dissolved in 100mL of deionized water at 50 ℃ to obtain a tannic acid solution. Adding 100mL of tannic acid solution into gelatin solution containing silica nanoparticles, graphene nanosheets, hydroxyapatite nanoparticles, fibroin nanoparticles and bioglass nanoparticles within 30min, rapidly stirring to combine gelatin molecules and tannic acid molecules to form micro-nano particles, and coating the nano particles. 165. Mu.L of glutaraldehyde, a crosslinking agent, was then added and stirred for 12hrs. After washing the nanoparticles with deionized water, the nanoparticles were freeze-dried to obtain gelatin/tannic acid/nanoparticle powder. The size and charge of the resulting nanoparticles are shown in table 14. The transmission electron microscope of the composite particles in which the silica is wrapped is shown in fig. 3.
TABLE 14
Core layer nanoparticle species | Particle size | Surface charge |
Silicon dioxide | 514.6nm | -14.7mV |
Graphene | 435.9nm | -19.3mV |
Hydroxyapatite | 775.1nm | -21.3mV |
Silk fibroin | 624.7nm | -19.2mV |
Bioglass | 724.7nm | -14.7mV |
And repeatedly blowing 0.4g of core-shell particle powder containing different core-layer particles and 1mL of deionized water for 10 times through a luer adapter injector at normal temperature to obtain the injectable self-repairing particle gel. The storage modulus G' of the particulate gel was obtained using the time-sweep mode of the rotational rheometer as shown in table 15. Where the frequency was 1Hz and the strain was 0.5%. Core-shell composite particles of different core-layer particle types exhibit different mechanical strengths.
Example 9
Using the suspension of protein polyphenol core-shell particles prepared in example 8, and taking the suspension of composite particles in which the core layer nanoparticles are silica as an example, copper chloride, ferric chloride, zinc chloride, and europium chloride were added to the solution respectively until the final solution concentration was 10mM, and the mixture was stirred for 12hrs, and the nanoparticles were repeatedly washed 3 times using deionization, to obtain metal composite protein polyphenol core-shell particles.
Repeatedly blowing 0.4g of protein/polyphenol core-shell structure particle powder compounded by different metal ions and 1mL of deionized water for 10 times through a luer adapter injector at normal temperature to obtain the injectable composite particle gel. The storage modulus G' of the particulate gel obtained using the time-sweep mode of the rotational rheometer is shown in table 16. Where the frequency was 1Hz and the strain was 0.5%.
TABLE 16
Type of metal | Storage modulus |
Cu | 58.6kPa |
Fe | 64.1kPa |
Zn | 51.2kPa |
Ce | 47.9kPa |
Example 10
Using the core-shell particle powder containing different core layer particles prepared in example 8, 0.4g of the particle powder, 5mg of sodium periodate, and 1mL of deionized water were repeatedly blown through a luer adapter syringe at normal temperature for 10 times to obtain an injectable particle gel. The storage modulus G' of the particulate gel obtained using the time-sweep mode of the rotational rheometer is shown in table 17. Where the frequency was 1Hz and the strain was 0.5%. The storage modulus G' of the composite particle gel is further improved because sodium periodate can induce covalent crosslinking of tannin molecules on the surface of the particles.
TABLE 17
Core layer nanoparticle species | Storage modulus |
Silicon dioxide | 57.6kPa |
Graphene | 51.9kPa |
Hydroxyapatite | 65.0kPa |
Silk fibroin | 54.3kPa |
Bioglass | 53.1kPa |
Example 11
Using the gelatin/tannic acid nanoparticle powder prepared in example 1, 0.4g of the particle powder was repeatedly beaten with 1mL of deionized water containing 20mg of silica nanoparticles, lithium magnesium silicate nanoparticles, nanoclay particles, hydroxyapatite nanoparticles, iron oxide magnetic nanoparticles, silk fibroin nanoparticles, polylactic acid nanoparticles, alginic acid and pullulan through a luer adapter syringe at normal temperature for 10 times to obtain an injectable particle gel. The storage modulus G' of the particulate gel obtained using the time-sweep mode of the rotational rheometer is shown in table 18. Where the frequency was 1Hz and the strain was 0.5%.
Watch 18
Components in aqueous solutions | Storage modulus |
Silica nanoparticles | 28.9kPa |
Lithium magnesium silicate nanoparticles | 25.1kPa |
Nano clay particles | 30.6kPa |
Hydroxyapatite nanoparticles | 20.7kPa |
Magnetic iron oxide nanoparticles | 19.8kPa |
Silk fibroin nanoparticles | 23.9kPa |
Polylactic acid nanoparticles | 21.7kPa |
Alginic acid | 15.2kPa |
Pullulan polysaccharide | 14.9kPa |
Example 12
Compression testing was performed using the gelatin/tannic acid particle gel obtained in example 1 at pH5, the colloidal gel after metal ion crosslinking in example 6, and the covalently crosslinked gelatin/tannic acid colloidal gel obtained in example 7. The colloidal gel was formed into a cylinder (diameter: 6.4mm, height: 6 mm) and the compression test was conducted at a loading rate of 0.0002 mm/s. The compressive strain and compressive strength of the samples are shown in table 19, and after covalent crosslinking, both the compressive strength and the compressive strain of the gel are significantly increased.
Watch 19
Example 13
Compression tests were performed using the gelatin/tannic acid/silica colloidal gel obtained in example 6, the core-shell colloidal gel after metal ion crosslinking in example 9, and the covalently crosslinked gelatin/tannic acid/silica colloidal gel obtained in example 10. The colloidal gel was formed into a cylinder (diameter: 6.4mm, height: 6 mm). The compression test was performed at a loading rate of 0.0002 mm/s. The compressive strain and compressive strength of the samples are shown in table 20, and the mechanical strength of the gel is significantly increased after covalent cross-linking.
Example 14
The gelatin/tannin particle gel obtained in example 1 at pH5 was used for the tissue adhesion test. After 0.1mL of the granular gel was lap-bonded to the surfaces of two pieces of glass (5.0 cm. Times.2.0 cm rectangles) in which the lap-overlapped area was (1.5 cm. Times.2.0 cm rectangles) and left to stand for 10 minutes, the lap-bonded sample was subjected to shear peeling (peeling rate: 10 mm/min) using a tensile tester having a 50N mechanical sensor, and the tissue adhesive strength was as shown in Table 21.
TABLE 21
20%(w/v) | 40%(w/v) | |
Adhesive strength | 12.8kPa | 32.1kPa |
Example 15
The gelatin/tannic acid/silica colloidal gel obtained in example 6 was used for the tissue adhesion test. 0.1mL of colloidal gel was injected to the surface of two pieces of glass (5.0 cm. Times.2.0 cm rectangle) bonded in an overlapping region (1.5 cm. Times.2.0 cm rectangle) by lap bonding for 10 minutes, and then the lap samples were subjected to shear peeling (peeling rate: 10 mm/min) using a tensile tester with a 50N load cell, and the tissue adhesive strength was as shown in Table 22.
TABLE 22
Adhesive strength | 15.8kPa |
Example 16
The gelatin/tannic acid/metal ion colloidal gel obtained in example 7 was used to perform a tissue adhesion test. 0.1mL of colloidal gel was injected to the surfaces of two pieces of glass (5.0 cm. Times.2.0 cm rectangles) bonded in an overlapping manner in which the overlapping region was (1.5 cm. Times.2.0 cm rectangles) and left to stand for 10min, and then the overlapped samples were subjected to shear peeling (peeling rate: 10 mm/min) using a tensile tester with a 50N load cell to obtain a peeling process stress-strain curve, and the adhesive strength was defined by the stress maximum point of the curve as shown in Table 23.
TABLE 23
Adhesive strength | 7.1kPa |
Example 17
The gelatin/tannin colloidal gel obtained in example 1 was used to simulate an in vivo dynamic environment by placing it on a shaker (30 rpm) at an ambient temperature of 37 ℃.1ml of PBS supernatant was taken up at 1d,3d,7d,14d and 21d, respectively, and then an equal amount of fresh PBS solution was added. The content of tannic acid is measured at each time point by using a high performance liquid chromatography kit, and the high performance liquid chromatography detection shows that tannic acid is slowly released in the colloidal gel at a relatively constant concentration, the uniform release can still be detected at the 21 st day, and the release amount is shown in figure 4, which indicates that the composite colloidal gel can continuously and slowly release polyphenol and can be used as a carrier of bioactive substances.
Example 18
Taking mouse primary mesenchymal stem cells as an example, the cell culture medium was changed every two days in proliferation culture (DMEM, containing 10% fetal bovine serum (FBS, gibco)) at 37 ℃,95% relative humidity and 5% carbon dioxide. Before use, cells were dissociated in Phosphate Buffered Saline (PBS) using a trypsin/EDTA solution (0.25% trypsin/0.02% EDTA) for 5 minutes and suspended in the medium for use. The cell suspension was directly dropped onto the surface of the colloidal gel exemplified in example 1 (pH 5) at a cell concentration of 5000 cells/cm 2 Inoculating, standing for 1hr, and adding culture medium.
The cytotoxicity of the gel material was examined by using Live/Dead fluorescent staining (Live/Dead assay). 2mM calcein (green labeled live cells) and 4mM ethidium homodimer (red fluorescence labeled dead cells) were added at room temperature and confocal laser scanning microscopy was used. The results are shown in FIG. 5, where green fluorescence represents live cells, red fluorescence represents dead cells, and 3T3 cells cultured on the hydrogel particles for a long time are all live cells, indicating excellent biocompatibility.
Example 19
Using the gelatin/tannic acid colloidal gel of example 1 (pH 5), the colloidal gel was prepared into a cylinder (diameter 8mm, height 2 mm). Staphylococcus aureus or Escherichia coli was cultured overnight in LB medium and then plated on the surface of an agar plate for 6 hours. The colloidal gel was added to the surface of the agar plate of the inoculated bacteria, and the mixture was placed in an incubator at 37 ℃ and incubated at relative humidity for 12 hours. The agar plate was photographed and the growth of bacteria around the cylindrical colloidal gel was observed. FIG. 6 shows no bacterial growth around the colloidal gel, indicating that the gel of the present invention is bacteriostatic.
Example 20
Taking the particle gel prepared in example 1 (pH 5) as an example, the particle gel is respectively blended with a natural active factor VEGF, an anticancer drug adriamycin, a protein drug immunoglobulin and a nucleic acid drug mRNA and placed on a shaker (30 r/min) at the ambient temperature of 37 ℃ so as to simulate the in vivo dynamic environment. 1ml of PBS supernatant was taken up at 1d,3d,7d,14d and 21d, respectively, and then an equal amount of fresh PBS solution was added. The amount of drug released was measured at each time point using ELISA kit, high performance liquid chromatography with three samples per group. Through detection, fig. 7 shows that each type of drug molecules in the colloidal gel are slowly released at a relatively constant concentration, and the uniform release can still be detected at 21 days, which indicates that the covalently crosslinkable colloidal gel has drug slow release performance and can be used as a carrier of bioactive substances.
Example 21
Treating the cells with an ROS inducer to obtain cells containing high ROS as a positive control; normal cells as negative control; the Ce ion-containing composite particles of example 6 were used for co-culture with cells with high ROS content. By using a probe for active oxygen DCFH-DA and Ru (dpp) 3 Cl 2 The above different groups were stained, and the content of active oxygen in the cells was observed. Stained cells were observed using the EVOS system and readings were taken using a multimode plate reader (PerkinElmer, USA) at 485nm excitation wavelength and 525nm emission wavelength. Wherein the green and red fluorescence signals are DCFH-DA and Ru (dpp) 3 Cl 2 And all the probes can represent ROS content. The fluorescence image of FIG. 8 shows that the red and green fluorescence intensities in normal cells are low, indicating that the ROS content is low (negative control group in the image). The green and red fluorescence signals were evident in cells treated with the ROS inducer (positive control in the figure), indicating that the cells contain high levels of ROS. After incubation treatment of the Ce ion composite particles and cells with high ROS content, the ROS content in the cells is remarkably reduced, and the surface Ce ion composite particles have anti-oxidation property (Ce ion composite particle groups in the figure).
Example 22
Mesenchymal stem cells were cultured in contact with 10mg/mL of the gelatin/tannin colloid gel of example 1 (pH 5), the Zn ion complex colloid gel of example 6 for 7 days, and then their osteogenic differentiation behavior was evaluated by alkaline phosphatase staining (ALP). Fig. 9 shows that the cell group treated with the composite protein particles and the Zn ion composite particles showed a higher degree of osteogenic differentiation characteristics compared to the blank control group. And the Zn ion compounded colloidal gel shows higher osteogenic differentiation performance than the pure colloidal gel.
Example 23
Endothelial cells HUVEC were co-cultured with 10mg/mL of the Cu ion complex colloidal gel of example 6, and proliferation and migration of endothelial cells were assessed by cell staining. FIG. 10 shows that co-culture with colloidal gel promotes endothelial cell proliferation compared to the blank control.
Example 24
Using the colloidal gel prepared in example 1 (pH 5), the non-covalently crosslinked particulate gel was loaded into a syringe and extrusion printed using a 3D bioprinter through a needle having a gauge of G16-23. And printing the material layer by layer according to a route designed by a set program to obtain the 3D biological printing support with the fine structure.
Example 25
Using the colloidal gel described in example 1 (pH 5), a total of 100. Mu.L of gel material was injected subcutaneously on both sides of SD rats: the subcutaneous filling effect is observed at time points of 1, 4, 8 and 12 weeks respectively, and experiments show that the particle gel can be stably filled in rats subcutaneously for 21 weeks, and the physiological conditions of the rats are stable.
It will be apparent to those skilled in the art from this disclosure that many changes and modifications can be made, or equivalents modified, in the embodiments of the invention without departing from the scope of the invention. Therefore, any simple modification, equivalent change and modification made to the above embodiments according to the technical essence of the present invention shall still fall within the protection scope of the technical solution of the present invention, unless the contents of the technical solution of the present invention are departed.
Claims (10)
1. A hydrogel material assembled by polyphenol and protein composite micro-nano particles is characterized in that:
the hydrogel material is formed by assembling through hydrophobic interaction and hydrogen bond interaction between polyphenol/protein composite micro-nano particles; preferably, after the hydrogel material is formed by assembling through hydrophobic interaction and hydrogen bond interaction between the polyphenol/protein composite micro-nano particles, an oxidant is added to enable covalent crosslinking between polyphenols to realize crosslinking between the polyphenol/protein composite micro-nano particles; the polyphenol/protein composite micro-nano particles are formed by induced assembly through hydrogen bond action, hydrophobic action or electrostatic action between a protein polymer chain and polyphenol; preferably, the polyphenol/protein composite micro-nano particles are formed by induced assembly through hydrogen bond interaction, hydrophobic interaction or electrostatic interaction between a protein polymer chain and polyphenol, and then the protein chain is covalently crosslinked by adding a crosslinking agent to form the stable micro-nano particles.
2. A hydrogel material assembled by micro-nano colloidal particles compounded by polyphenol, protein and metal ions is characterized in that:
the hydrogel material is formed by assembling through hydrophobic interaction, hydrogen bond interaction and metal coordination interaction among polyphenol/protein composite micro-nano particles; preferably, after the hydrogel material is formed by assembling through hydrophobic interaction, hydrogen bond interaction and metal coordination between the polyphenol/protein composite micro-nano particles, an oxidant is added to enable covalent crosslinking between polyphenols to realize crosslinking between the polyphenol/protein composite micro-nano particles; the polyphenol/protein composite micro-nano particles are obtained by adding metal ions into the polyphenol/protein composite micro-nano particles of claim 1 to form coordination with polyphenol in the particles.
3. A hydrogel material assembled by rigid nanoparticle-polyphenol/protein composite core-shell structure micro-nano particles is characterized in that:
the hydrogel material is formed by assembling through hydrophobic interaction and hydrogen bond interaction between core-shell structure micro-nano particles; preferably, after the hydrogel material is formed by assembling through hydrophobic interaction and hydrogen bond interaction among the composite micro-nano colloidal particles, the crosslinking among the core-shell structure micro-nano particles is realized through covalent crosslinking among polyphenols by adding an oxidant; the core layer of the core-shell structure micro-nano particles is made of rigid nano particle materials, the shell layer is made of polyphenol/protein composite particles, and the polyphenol/protein composite particles are formed through hydrogen bond action, hydrophobic action and electrostatic action between protein molecules and polyphenol molecules; preferably, after the protein molecules and the polyphenol molecules are formed through hydrogen bond interaction, hydrophobic interaction and electrostatic interaction, a cross-linking agent is added to covalently cross-link protein chains to form the stable micro-nano particles.
4. A core-shell structured colloidal particle material complexed by rigid nanoparticles-polyphenols/proteins/metal ions, characterized in that:
the hydrogel material is formed by assembling hydrophobic interaction, hydrogen bond interaction and metal coordination interaction among the core-shell structure micro-nano particles; preferably, after the hydrogel material is formed by assembling through hydrophobic interaction, hydrogen bond interaction and metal coordination interaction between the core-shell structure micro-nano particles, an oxidant is added to enable covalent crosslinking between polyphenols to realize crosslinking between the core-shell structure micro-nano particles; the core layer of the core-shell structure micro-nano particle is composed of rigid nano particle materials, the shell layer is composed of polyphenol/protein/metal composite particles, and the polyphenol/protein/metal composite particles are obtained by adding metal ions into the polyphenol/protein composite particles of claim 3 to form coordination with polyphenol in the particles.
5. The hydrogel material according to any one of claims 1 to 4, wherein the polyphenol material is selected from one or more of gallic acid, gallic acid esters, epigallocatechin, quercetin, curcumin, tannic acid, catechol, dopamine;
the protein material is selected from pure structural protein, pure structural protein derivatives, pure structural protein and hydrophilic polymer material mixture; the pure structural protein is gelatin protein, sericin, silk fibroin, albumin, serum protein, keratin, elastin, hemoglobin, immunoglobulin, fibrin, fluorescent protein GFP;
the oxidant in the polyphenol oxidation process is sodium dichromate, potassium permanganate, sodium periodate, sodium peroxide, potassium peroxide and hydrogen peroxide;
the metal ions used for the coordination interaction of the metal ions are one or more of aluminum, vanadium, chromium, manganese, iron, cobalt, nickel, copper, zinc, zirconium, molybdenum, ruthenium, rhodium, cadmium, cerium, europium, gadolinium and terbium ions;
the rigid nanoparticles are silica nanoparticles, lithium magnesium silicate nanoparticles, nanoclay particles, hydroxyapatite nanoparticles, iron oxide magnetic nanoparticles, barium titanate nanoparticles, graphene nanosheets, carbon nanotubes, bioglass nanoparticles, black phosphorus nanosheets, silk fibroin nanoparticles, polylactic acid nanoparticles, polyethylene nanoparticles, polystyrene nanoparticles; when the size of the composite micro-nano particles is 10 nm-5 mu m, the volume fraction of the composite micro-nano particles in the total volume of the hydrogel is 2-120 v/v%; when the size of the composite micro-nano particles is 5-500 mu m, the volume fraction of the composite micro-nano particles in the total volume of the hydrogel is 50-120 v/v%.
6. The preparation method of the polyphenol and protein assembled micro-nano particle hydrogel material of claim 1, wherein the hydrogel comprises the following preparation steps:
(1) Dissolving protein in aqueous solution at 10-80 deg.c to obtain 0.1-10 w/v% concentration protein solution; dissolving polyphenol in aqueous solution at 10-90 ℃ to obtain polyphenol aqueous solution with the concentration of 0.1-10 w/v%;
(2) Adjusting the pH value of the protein solution to 3-7, adding a polyphenol solution into the protein solution to obtain a protein/polyphenol composite particle solution, and freeze-drying to obtain composite particle powder; wherein the mass ratio of the protein to the polyphenol is 0.1-20, preferably 1-20; preferably, adding a macromolecular cross-linking agent into the protein/polyphenol composite particle solution at normal temperature to stabilize the composite particles for reaction for 1-12 hrs, wherein the mass ratio of the protein to the macromolecular cross-linking agent is 0.1-100; cleaning to obtain a protein/polyphenol composite particle dispersion liquid, and freeze-drying the particle dispersion liquid to obtain composite particle powder;
(3) Mixing the protein/polyphenol composite particle powder with an aqueous solution to obtain an injectable self-repairing colloidal gel; preferably, the injectable and self-repairing colloidal gel is further added with an oxidant to polymerize polyphenol on the surfaces of the composite particles to obtain a crosslinked colloidal hydrogel;
in the step (2), the cross-linking agent is one or more of carbodiimide/N-hydroxysuccinimide, formaldehyde, acetaldehyde, glyceraldehyde, aromatic aldehyde, glutaraldehyde, succinaldehyde, genipin, diglycidyl ether, dialkene oxide, divinyl sulfone, polyfunctional aziridine and diisocyanate;
in the step (3), the oxidant is sodium dichromate, potassium permanganate, sodium periodate, sodium peroxide, potassium peroxide and hydrogen peroxide;
preferably, the aqueous solution is water or an aqueous solution blended with other substances; the other substances are one or more of vitamins, amino acids, mineral elements, microecological regulators, silicon dioxide nanoparticles, lithium magnesium silicate nanoparticles, nano clay particles, hydroxyapatite nanoparticles, iron oxide magnetic nanoparticles, barium titanate nanoparticles, graphene nanosheets, carbon nanotubes, bioglass nanoparticles, black phosphorus nanosheets, silk fibroin nanoparticles, polylactic acid nanoparticles, polyethylene nanoparticles, polystyrene nanoparticles, alginic acid, hyaluronic acid, chitosan, chondroitin sulfate, pullulan, xanthan gum and starch.
7. The method for preparing a polyphenol, protein and metal ion assembled colloidal particle hydrogel material as set forth in claim 2, characterized in that:
(1) Dissolving protein in aqueous solution at 10-80 ℃ to obtain protein aqueous solution with the concentration of 0.1-10 w/v%; dissolving polyphenol in water solution at 10-90 deg.c to obtain polyphenol water solution in the concentration of 0.1-10 w/v%;
(2) Adjusting the pH value of the protein solution to 3-7, and adding a polyphenol solution into the protein solution to obtain a protein/polyphenol composite particle solution, wherein the mass ratio of the protein to the polyphenol is 0.1-20, preferably 1-20; adding metal ions into the particle solution, stirring to obtain a particle dispersion liquid, wherein the concentration of the metal ions is 1 mM-10M, centrifuging, washing and freeze-drying the particle dispersion liquid to obtain composite particle powder. Preferably, the particle solution is added with a macromolecular cross-linking agent at normal temperature to stabilize the composite particles, and then metal ions are added after the composite particles react for 1 to 12hrs, wherein the mass ratio of the protein to the macromolecular cross-linking agent is 0.1 to 100;
(3) Mixing the protein/polyphenol composite particle powder with an aqueous solution to obtain an injectable self-repairing colloidal gel; preferably, the injectable and self-repairing colloidal gel is further added with an oxidation cross-linking agent to polymerize polyphenol on the surfaces of the composite particles to obtain a cross-linked colloidal hydrogel;
in the step (2), the cross-linking agent is one or more of carbodiimide/N-hydroxysuccinimide, formaldehyde, acetaldehyde, glyceraldehyde, aromatic aldehyde, glutaraldehyde, succinaldehyde, genipin, diglycidyl ether, dialkene oxide, divinyl sulfone, polyfunctional aziridine and diisocyanate;
in the step (3), the oxidation crosslinking agent is sodium dichromate, potassium permanganate, sodium periodate, sodium peroxide, potassium peroxide and hydrogen peroxide; the metal ions used for the coordination crosslinking of the metal ions are one or more of aluminum, vanadium, chromium, manganese, iron, cobalt, nickel, copper, zinc, zirconium, molybdenum, ruthenium, rhodium, cadmium, cerium, europium, gadolinium and terbium ions;
preferably, the aqueous solution is water or an aqueous solution blended with other substances; the other substances are one or more of vitamins, amino acids, mineral elements, microecological regulators, silicon dioxide nanoparticles, lithium magnesium silicate nanoparticles, nano clay particles, hydroxyapatite nanoparticles, iron oxide magnetic nanoparticles, barium titanate nanoparticles, graphene nanosheets, carbon nanotubes, bioglass nanoparticles, black phosphorus nanosheets, silk fibroin nanoparticles, polylactic acid nanoparticles, polyethylene nanoparticles, polystyrene nanoparticles, alginic acid, hyaluronic acid, chitosan, chondroitin sulfate, pullulan, xanthan gum and starch.
8. The method for preparing the colloidal particle material with the core-shell structure of the nanoparticle-polyphenol compound protein molecule as claimed in claim 3, wherein the compound particle comprises the following preparation steps:
(1) Dissolving protein molecules in an aqueous solution at 10-80 ℃ to obtain a protein aqueous solution with the concentration of 0.1-10 w/v%; dissolving polyphenol in aqueous solution at 10-90 deg.c to obtain polyphenol water solution with concentration of 0.1-10 w/v%;
(2) Adding rigid nano particles into the protein aqueous solution, adjusting the pH value of the solution to 3-7, and adding a polyphenol solution to obtain a core-shell structure composite particle solution; freeze drying to obtain composite particle powder; wherein the mass ratio of the protein to the polyphenol is 0.1-20, and the mass ratio of the protein to the rigid nano-particles is 0.1-30; preferably, at normal temperature, adding a cross-linking agent into the composite particle solution for further cross-linking and stabilizing the composite particles for reaction for 1-12 h, wherein the mass ratio of the protein to the macromolecular cross-linking agent is 0.1-100; cleaning to obtain a composite particle dispersion liquid of protein/polyphenol/nanoparticles, and freeze-drying the particle dispersion liquid to obtain composite particle powder;
(3) The composite particle powder and the aqueous solution are blended to obtain injectable self-repairing colloidal gel; preferably, the injectable self-repairing colloidal gel further comprises an oxidative crosslinking agent or metal ions to polymerize the polyphenol on the surface of the composite particles, so as to obtain a crosslinked colloidal hydrogel;
in the step (2), the cross-linking agent is one or more of carbodiimide/N-hydroxysuccinimide, formaldehyde, acetaldehyde, glyceraldehyde, aromatic aldehyde, glutaraldehyde, succinaldehyde, genipin, diglycidyl ether, dialkene oxide, divinyl sulfone, polyfunctional aziridine and diisocyanate; the rigid nanoparticles are silica nanoparticles, lithium magnesium silicate nanoparticles, nanoclay particles, hydroxyapatite nanoparticles, iron oxide magnetic nanoparticles, barium titanate nanoparticles, graphene nanosheets, carbon nanotubes, bioglass nanoparticles, black phosphorus nanosheets, silk fibroin nanoparticles, polylactic acid nanoparticles, polyethylene nanoparticles, polystyrene nanoparticles;
in the step (3), the oxidation crosslinking agent is sodium dichromate, potassium permanganate, sodium periodate, sodium peroxide, potassium peroxide and hydrogen peroxide; the metal ions used for the coordination crosslinking of the metal ions are one or more of aluminum, vanadium, chromium, manganese, iron, cobalt, nickel, copper, zinc, zirconium, molybdenum, ruthenium, rhodium, cadmium, cerium, europium, gadolinium and terbium ions;
preferably, the aqueous solution is water or an aqueous solution blended with other substances; the other substances are one or more of vitamins, amino acids, mineral elements, microecological regulators, silicon dioxide nanoparticles, lithium magnesium silicate nanoparticles, nano clay particles, hydroxyapatite nanoparticles, iron oxide magnetic nanoparticles, barium titanate nanoparticles, graphene nanosheets, carbon nanotubes, bioglass nanoparticles, black phosphorus nanosheets, silk fibroin nanoparticles, polylactic acid nanoparticles, polyethylene nanoparticles, polystyrene nanoparticles, alginic acid, hyaluronic acid, chitosan, chondroitin sulfate, pullulan, xanthan gum and starch.
9. The method for preparing the core-shell structure colloidal particle material composed of nanoparticles, polyphenol, protein and metal molecules as claimed in claim 3, wherein the composite particles comprise the following preparation steps:
(1) Dissolving protein molecules in an aqueous solution at 10-80 ℃ to obtain a protein aqueous solution with the concentration of 0.1-10 w/v%; dissolving polyphenol in water solution at 10-90 deg.c to obtain polyphenol water solution in the concentration of 0.1-10 w/v%;
(2) Adding rigid nano particles into the protein aqueous solution, adjusting the pH value of the solution to 3-7, and adding a polyphenol solution to obtain a core-shell structure composite particle solution; wherein the mass ratio of the protein to the polyphenol is 0.1-20, and the mass ratio of the protein to the rigid nano-particles is 0.1-30; adding metal ions into the particle dispersion liquid, stirring, centrifuging, washing and freeze-drying the particle dispersion liquid to obtain composite particle powder, wherein the concentration of the metal ions is 1 mM-10M; preferably, at normal temperature, adding a cross-linking agent into the core-shell structure composite particle solution for further cross-linking and stabilizing the composite particles for reaction for 1-12 h, wherein the mass ratio of the protein to the macromolecular cross-linking agent is 0.1-100; cleaning to obtain a composite particle dispersion liquid of protein/polyphenol/nanoparticles;
(3) The composite particle powder and the aqueous solution are blended to obtain injectable self-repairing colloidal gel; preferably, the injectable self-repairing colloidal gel further comprises an oxidative crosslinking agent or metal ions to polymerize the polyphenol on the surface of the composite particles, so as to obtain a crosslinked colloidal hydrogel;
in the step (2), the cross-linking agent is one or more of carbodiimide/N-hydroxysuccinimide, formaldehyde, acetaldehyde, glyceraldehyde, aromatic aldehyde, glutaraldehyde, succinaldehyde, genipin, diglycidyl ether, dialkene oxide, divinyl sulfone, polyfunctional aziridine and diisocyanate; the rigid nanoparticles are silica nanoparticles, lithium magnesium silicate nanoparticles, nanoclay particles, hydroxyapatite nanoparticles, iron oxide magnetic nanoparticles, barium titanate nanoparticles, graphene nanosheets, carbon nanotubes, bioglass nanoparticles, black phosphorus nanosheets, silk fibroin nanoparticles, polylactic acid nanoparticles, polyethylene nanoparticles, polystyrene nanoparticles;
in the step (3), the oxidative crosslinking agent is sodium dichromate, potassium permanganate, sodium periodate, sodium peroxide, potassium peroxide and hydrogen peroxide; the metal ions used for the coordination crosslinking of the metal ions are one or more of aluminum, vanadium, chromium, manganese, iron, cobalt, nickel, copper, zinc, zirconium, molybdenum, ruthenium, rhodium, cadmium, cerium, europium, gadolinium and terbium ions;
preferably, the aqueous solution is water or an aqueous solution blended with other substances; the other substances are one or more of vitamins, amino acids, mineral elements, microecological regulators, silicon dioxide nanoparticles, lithium magnesium silicate nanoparticles, nano clay particles, hydroxyapatite nanoparticles, iron oxide magnetic nanoparticles, barium titanate nanoparticles, graphene nanosheets, carbon nanotubes, bioglass nanoparticles, black phosphorus nanosheets, silk fibroin nanoparticles, polylactic acid nanoparticles, polyethylene nanoparticles, polystyrene nanoparticles, alginic acid, hyaluronic acid, chitosan, chondroitin sulfate, pullulan, xanthan gum and starch.
10. Use of the hydrogel material according to any one of claims 1 to 4 for the preparation of an anti-inflammatory, antioxidant, antibacterial scaffold for the repair filling of wounds or defects in bone tissue, cartilage tissue, muscle, blood vessels, skin;
or in the preparation of a carrier or a bracket containing medicinal components, wherein the medicinal components are one or more of vitamins, amino acids, mineral elements, microecological regulators, growth factors, micromolecular medicaments, protein macromolecular medicaments, antibiotic medicaments, hormone medicaments, anesthetic medicaments, antiviral medicaments, antibacterial medicaments, anticancer medicaments, immunoregulation medicaments, nucleic acid medicaments or live cells;
or the application in preparing superficial skin and subcutaneous filler; preferably in medical and cosmetic fillings;
or in the preparation of bio-inks, preferably bio-printing inks for printing with living cells; preferably, when the method is applied, the colloidal particles and the aqueous solution are blended to obtain colloidal particle gel, then the colloidal particle gel is mixed with the cell suspension to obtain cell-loaded colloidal gel, namely biological ink, and the ink is extruded or subjected to ink-jet 3D printing to obtain a scaffold with a 3D structure, so as to obtain a cell-loaded printing scaffold;
or in the preparation of tissue adhesive gel material, wherein the composite microsphere particle size is less than 10 μm, and the adhesive strength between the colloidal gel and the tissue is 5-100 kPa; injecting the gel to the tissue injury part in vivo, and waiting for 1-30 min to realize stable adhesion between the colloidal gel and the tissue;
or the application in the hemostatic sealing powder; preferably, when applied to the hemostatic sealing powder, the hemostatic sealing powder comprises the composite micro-nano particle powder prepared according to claims 6 to 9.
Or as a metal ion slow release carrier to realize wound repair.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211112129.2A CN115521484A (en) | 2022-09-13 | 2022-09-13 | Injectable colloidal gel material composed of polyphenol and protein composite particles and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211112129.2A CN115521484A (en) | 2022-09-13 | 2022-09-13 | Injectable colloidal gel material composed of polyphenol and protein composite particles and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115521484A true CN115521484A (en) | 2022-12-27 |
Family
ID=84698215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211112129.2A Pending CN115521484A (en) | 2022-09-13 | 2022-09-13 | Injectable colloidal gel material composed of polyphenol and protein composite particles and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115521484A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116236609A (en) * | 2023-05-09 | 2023-06-09 | 天津包钢稀土研究院有限责任公司 | Antibacterial and anti-inflammatory bandage and preparation method and application thereof |
CN116251233A (en) * | 2023-05-16 | 2023-06-13 | 北京大学第三医院(北京大学第三临床医学院) | High-adhesion hydrogel for promoting meniscus injury repair and preparation method thereof |
CN117461846A (en) * | 2023-12-26 | 2024-01-30 | 中国农业大学 | Preparation method and application of mineral element-polyphenol@protein compound |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108114287A (en) * | 2017-12-22 | 2018-06-05 | 四川大学 | Albumen-polyphenol complex microsphere and its preparation method and application |
CN108653741A (en) * | 2018-05-24 | 2018-10-16 | 华中科技大学同济医学院附属协和医院 | A kind of natural sericin microballoon and its preparation method and application of metal organic coordination polymer package |
CN110760076A (en) * | 2019-11-06 | 2020-02-07 | 大连理工大学 | Injectable high-strength composite hydrogel based on colloidal particle-iPRF dual-network structure and preparation method and application thereof |
CN114432496A (en) * | 2022-01-25 | 2022-05-06 | 大连理工大学 | Preparation method of injectable secondary mechanically-reinforced double-network hydrogel compounded by natural polymer organic nano |
CN114558164A (en) * | 2022-01-21 | 2022-05-31 | 大连理工大学 | Preparation method and application of injectable and hemostatic adhesive hydrogel based on gelatin particles |
CN114796598A (en) * | 2022-05-06 | 2022-07-29 | 南京工业大学 | Antibacterial hydrogel for promoting healing of refractory wound surface and application thereof |
-
2022
- 2022-09-13 CN CN202211112129.2A patent/CN115521484A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108114287A (en) * | 2017-12-22 | 2018-06-05 | 四川大学 | Albumen-polyphenol complex microsphere and its preparation method and application |
CN108653741A (en) * | 2018-05-24 | 2018-10-16 | 华中科技大学同济医学院附属协和医院 | A kind of natural sericin microballoon and its preparation method and application of metal organic coordination polymer package |
CN110760076A (en) * | 2019-11-06 | 2020-02-07 | 大连理工大学 | Injectable high-strength composite hydrogel based on colloidal particle-iPRF dual-network structure and preparation method and application thereof |
CN114558164A (en) * | 2022-01-21 | 2022-05-31 | 大连理工大学 | Preparation method and application of injectable and hemostatic adhesive hydrogel based on gelatin particles |
CN114432496A (en) * | 2022-01-25 | 2022-05-06 | 大连理工大学 | Preparation method of injectable secondary mechanically-reinforced double-network hydrogel compounded by natural polymer organic nano |
CN114796598A (en) * | 2022-05-06 | 2022-07-29 | 南京工业大学 | Antibacterial hydrogel for promoting healing of refractory wound surface and application thereof |
Non-Patent Citations (3)
Title |
---|
HUI JIE ZHANG等: ""Dynamic bonds enable high toughness and multifunctionality in gelatin/tannic acid-based hydrogels with tunable mechanical properties"", 《SOFT MATTER》, vol. 17, 17 September 2021 (2021-09-17), pages 9399 - 9409 * |
JIE WANG等: ""Self-Healing and Highly Stretchable Gelatin Hydrogel for Self- Powered Strain Sensor"", 《ACS APPL. MATER. INTERFACES》, vol. 12, 6 December 2019 (2019-12-06), pages 1558 - 1566 * |
QIUXIA ZHAO等: ""Tannin-Tethered Gelatin Hydrogels with Considerable Self-Healing and Adhesive Performances"", 《MACROMOL. MATER. ENG.》, vol. 304, 7 February 2019 (2019-02-07), pages 1800664 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116236609A (en) * | 2023-05-09 | 2023-06-09 | 天津包钢稀土研究院有限责任公司 | Antibacterial and anti-inflammatory bandage and preparation method and application thereof |
CN116251233A (en) * | 2023-05-16 | 2023-06-13 | 北京大学第三医院(北京大学第三临床医学院) | High-adhesion hydrogel for promoting meniscus injury repair and preparation method thereof |
CN117461846A (en) * | 2023-12-26 | 2024-01-30 | 中国农业大学 | Preparation method and application of mineral element-polyphenol@protein compound |
CN117461846B (en) * | 2023-12-26 | 2024-04-16 | 中国农业大学 | Preparation method and application of mineral element-polyphenol@protein compound |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113278168B (en) | Two-field coupling cross-linked injectable plastic printable particle hydrogel material and preparation method and application thereof | |
CN115521484A (en) | Injectable colloidal gel material composed of polyphenol and protein composite particles and preparation method and application thereof | |
Hu et al. | Dual-crosslinked mussel-inspired smart hydrogels with enhanced antibacterial and angiogenic properties for chronic infected diabetic wound treatment via pH-responsive quick cargo release | |
Zhang et al. | Polyphenol scaffolds in tissue engineering | |
Farokhi et al. | Functionalized silk fibroin nanofibers as drug carriers: Advantages and challenges | |
Dadras Chomachayi et al. | Electrospun nanofibers comprising of silk fibroin/gelatin for drug delivery applications: thyme essential oil and doxycycline monohydrate release study | |
Zahiri et al. | Encapsulation of curcumin loaded chitosan nanoparticle within poly (ε-caprolactone) and gelatin fiber mat for wound healing and layered dermal reconstitution | |
Ying et al. | In situ formed collagen-hyaluronic acid hydrogel as biomimetic dressing for promoting spontaneous wound healing | |
Lu et al. | Medical applications based on supramolecular self-assembled materials from tannic acid | |
Das et al. | Biomolecule-assisted synthesis of biomimetic nanocomposite hydrogel for hemostatic and wound healing applications | |
Kretlow et al. | Injectable matrices and scaffolds for drug delivery in tissue engineering | |
Mandal et al. | Silk fibroin/gelatin multilayered films as a model system for controlled drug release | |
CN101280467B (en) | Preparation and application of chitosan-based nano-fiber | |
Samadian et al. | A novel alginate-gelatin microcapsule to enhance bone differentiation of mesenchymal stem cells | |
Kang et al. | 3D bioprinting of dECM/Gel/QCS/nHAp hybrid scaffolds laden with mesenchymal stem cell-derived exosomes to improve angiogenesis and osteogenesis | |
Xu et al. | Development of porous chitosan/tripolyphosphate scaffolds with tunable uncross-linking primary amine content for bone tissue engineering | |
Trindade et al. | Nanocomposite particles for bio-applications: materials and bio-interfaces | |
CN115521627A (en) | Structural protein/hyaluronic acid composite micro-nano particle, particle hydrogel material and application | |
CN106178114A (en) | Mixing hollow microcapsule, comprise its soft tissue support and preparation method | |
Habibizadeh et al. | Surface modification of neurotrophin‐3 loaded PCL/chitosan nanofiber/net by alginate hydrogel microlayer for enhanced biocompatibility in neural tissue engineering | |
CN110433327A (en) | A kind of bone renovating material and preparation method thereof | |
Laghezza Masci et al. | Characterization of collagen/lipid nanoparticle–curcumin cryostructurates for wound healing applications | |
Tehrani et al. | Protein and polysaccharide-based asymmetric mat with tuned bilayer configuration for enhanced wound healing efficiency | |
EP3151874B1 (en) | Collagen biomaterials | |
Li et al. | Engineering superstable islets-laden chitosan microgels with carboxymethyl cellulose coating for long-term blood glucose regulation in vivo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |